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Abstract 
Objectives: 
Two simple spectrophotometric methods were developed for 
determination of cefprozil in pure bulk form and pharmaceutical 
formulations. 
Methodology: 
The first colorimetric method was based on the coupling of 
cefprozil, after being hydrolyzed by sodium hydroxide ,0.1 N (NaOH), 
with ascorbic acid as a chromogen, while the second method utilizes a 
direct reaction between cefprozil and 1N NaOH. 
Results: 
It has been established that cefprozil reacts with ascorbic acid to 
form a water soluble coloured 1:1 complex with maximum absorbance at 
408 nm, and at 486 nm for the colored product with NaOH (second 
proposed method).For the first proposed method the color developed 
immediately and remained stable for at least 3 hours. The optimum 
conditions for both methods were investigated and incorporated into their 
respective procedures. The validity of the proposed methods was tested 
by analyzing samples of cefprozil under the optimum experimental 
conditions employed, Beer’s law was found to be valid over the 
concentration range 1.23 X 10-05- 6.14 X 10-05M. The molar absorptivity 
(ε) of the products was7212 l mol-1 cm-1 (first proposed method), and 
7429 l mol-1 cm-1(second proposed method).These values, being relatively 
high, confirms the sensitivity of the methods. Regression analysis of 
Beer’s plot showed good correlation (R2 = 0.998) for the first method and 
(R2 = 0.999) for the second one, with a detection limit of 0.964µg/ml and 
0.9265µg/ml respectively. The precision of the methods was determined 
on three different concentrations of cefprozil. The results showed a low 
standard deviation (SD) which varied from 7.81 x 10-3 to 1.06 x 10-2 (first 
proposed method), and 5.77 X 10-04 – 3.2 X 10-05 (second proposed 
method) in the range 2.45 X 10-05- 4.9 X 10-05M.  The assay results were 
99.89±0.87% (first proposed method), 98.90±0.50% (second proposed 
method). 
 The added recovery% for the commercial tablets was 100.7±2.173 
which reflected no interference by the tablets excipients. The results 
obtained were sufficiently accurate, reproducible and in accordance with 
those given by the official method (HPLC).  
Difference spectrophotometry (∆ A method) was applicable for the 
first proposed method. The obtained results for the degraded amount in 
intact bulk cefprozil and the tablets form (cefzil) were 4.93±0.17 and 
5.50±0.28 respectively. 
The degradation rate rate,t½ and t90 for cefprozil when exposed to 
different concentrations of NaOH (0.2,0.5 and 1.0 N) was studied 
utilizing the official HPLC method. The results showed that the 
degradation rate increased, and consequently the t½ and t90 decreased 
with increased NaOH concentration. 
Conclusion:   
The results of the assay were 99.89±0.87% (first proposed 
method), 98.90±0.50% (second proposed method), with good precision 
and accuracy of the two methods and good recovery %. 
 
 
 
    
 
 
 
 
 ﻣﻠﺨﺺ اﻷﻃﺮوﺣﺔ
 
  :اﻻهﺪاف 
 ﻟﻠﺘﺤﻠﻴﻞ اﻟﻜﻤِﻲ ﺘﺎن ﺑﺴﻴﻄﺘﺎن ﻃﻴﻔﻴﺘﺎنﻃﺮﻳﻘ هﺬﻩ اﻟﺪراﺳﺔ ﻓﻲ أﺳﺘﺨﺪﻣﺖ
  .ﻴِﺔﻧواﻟﺼﻴﺎﻏﺎِت اﻟﺼﻴﺪﻻﺻﻮرﺗﻪ اﻟﻨﻘﻴﺔ ﻓﻲ  ﻟﻌﻘﺎر اﻟﺴﻴﻔﺒﺮوزﻳﻞ
  :ﻃﺮق اﻟﻌﻤﻞ
دة ﻣﻠﻮﻧﺔ آﻤﺎاﻷﺳﻜﻮرﺑﻴﻚ أﺳﻴﺪ  ﺨﺪُمَﺗﺴﺘ اﻟﺘﺤﻠﻴﻞ اﻟﻠﻮﻧﻲ اﻷوﻟﻰ   ﻃﺮﻳﻘﺔ
ﺑﻬﻴﺪروآﺴﻴﺪ اﻟﺼﻮدﻳﻮم، ( ﺗﻜﺴﻴﺮﻩ)ﻴﻠﻪ ﺎﻟﺴﻴﻔﺒﺮوزﻳﻞ ﺑﻌﺪ ﺗﺤﻠﺑﻋﻨﺪ اﻻﻗﺘﺮان 
أﻣﺎ اﻟﻄﺮﻳﻘﺔ اﻟﺜﺎﻧﻴﺔ ﻓﺘﻌﺘﻤﺪ ﻋﻠﻰ اﻟﺘﺤﻠﻴﻞ اﻟﻤﺒﺎﺷﺮ ﻟﻠﺴﻴﻔﺒﺮوزﻳﻞ ﺑﻮاﺳﻄﺔ 
  .هﻴﺪروآﺴﻴﺪ اﻟﺼﻮدﻳﻮم
  :اﻟﻨﺘﺎﺋﺞ
 ﻟَﺘﺸﻜﻴﻞ اﻷﺳﻜﻮرﺑﻴﻚ أﺳﻴﺪ  َﻣﻊاﻟﺴﻴﻔﺒﺮوزﻳﻞ ﻳﺘﻔﺎﻋﻞ ﺑﺄّنﻟﻘﺪ وﺟﺪ  
  ﻋﻨﺪذو اﻣﺘﺼﺎﺻﻴﺔ ﻗﺼﻮى  ﻗﺎﺑﻞ ﻟﻠﺬوﺑﺎِن ِ ﻓﻲ اﻟﻤﺎء  1:1 ﺑﻨﺴﺒﺔ ﻣﻠّﻮِنﻌﻘﺪ ﻣ 
  ﻧﺎﻧﻮﻣﺘﺮﻟﻠﻨﺎﺗﺞ اﻟﻤﻠﻮن ﻣﻊ هﻴﺪروآﺴﻴﺪ اﻟﺼﻮدﻳﻮم684ﻧﺎﻧﻮﻣﺘﺮ، وﻋﻨﺪ  804
 ﻟﻤﺪةﻳﺪوم ﻋﻠﻰ اﻻﻗﻞ   ﻓﻮرًا وﻳﺘﻜﻮن اﻟﻠﻮن (. اﻟﺘﺤﻠﻴﻞ اﻟﻠﻮﻧﻲ اﻟﺜﺎﻧﻴﺔﻃﺮﻳﻘﺔ)
ﺗﻢ اﺧﺘﺒﺎر اﻟﻈﺮوف اﻟﻤﻌﻤﻠﻴﺔ اﻟﻤﻨﺎﺳﺒﺔ ﻟﻠﺘﺠﺮﺑﺔ .  دون ﺗﻐﻴﻴﺮﺛﻼﺛﺔ ﺳﺎﻋﺎت
ﺻﻼﺣﻴﺔ اﻟﻄﺮﻳﻘِﺔ . ﻻﻋﻄﺎء أﻓﻀﻞ اﻟﻨﺘﺎﺋﺞ وﺗﻢ ادﺧﺎﻟﻬﺎ ﻓﻲ ﻃﺮﻳﻘﺔ اﻟﺘﺤﻀﻴﺮ
اﻟﻤﺨﺘﺒﺮﻳﺔ  اﻟﻈﺮوفﺗﺤﺖ  اﻟﺴﻴﻔﺒﺮوزﻳﻞ اﻟُﻤﻘَﺘَﺮﺣِﺔ إﺧﺘﺒﺮْت ﺑَﺘﺤﻠﻴﻞ ﻋﻴﻨﺎِت
  اﻟﻤﻮﻻري ﻋﻠﻰ ﻣﺪى اﻟﺘﺮآﻴﺰ ﻳﺘﻤﺎﺷﻲ ﻗﺎﻧﻮن ﺑﻴﺮﺣﻴﺚ وﺟﺪ أن  ،اﻟﻤﺜﻠِﻰ
 2127ﺑﺎﻣﺘﺼﺎﺻﻴﺔ ﻣﻮﻻرﻳﺔ  5 -01 x41.6 -5 -01 x32.1
 ﺳﻨﺘﻴﻤﺘﺮ.ﻣﻮل/ﻟﺘﺮ9247 و( اﻟﺘﺤﻠﻴﻞ اﻟﻠﻮﻧﻲ اﻷوﻟﻰﻃﺮﻳﻘﺔ )ﺳﻨﺘﻴﻤﺘﺮ.ﻣﻮل/ﻟﺘﺮ
 ﻧﺴﺒﻴًﺎ، ُﻳﺆّآُﺪ ﺔ أْن هﺬﻩ اﻟﻘﻴﻤِﺔ ﻋﺎﻟﻴﺣﻘﻴﻘﺔ  (. اﻟﺘﺤﻠﻴﻞ اﻟﻠﻮﻧﻲ اﻟﺜﺎﻧﻴﺔﻃﺮﻳﻘﺔ)
 ﻋﻼﻗﺔ ﺧﻄﻴﺔ ي ﻟﻤﻨﺤﻨﻲ ﺑﻴﺮ أﻇﻬﺮﻧﺤﺪاراﻹﺘﺤﻠﻴُﻞ اﻟ. ﺣّﺴﺎﺳﻴَﺔ اﻟﻄﺮﻳﻘِﺔ
( 999.0= ﻣﻌﺎﻣﻞ اﻻرﺗﺒﺎط)ﻟﻠﻄﺮﻳﻘﺔ اﻷوﻟﻰ، و( 899.0= ﻣﻌﺎﻣﻞ اﻻرﺗﺒﺎط)
ﺮآﺐ ﻳﻤﻜﻦ اﻟﻜﺸﻒ ﻋﻨﻬﺎ ﺑﻬﺬﻩ ﻟﻠﻄﺮﻳﻘﺔ اﻟﺜﺎﻧﻴﺔ، ووﺟﺪ أن أﻗﻞ آﻤﻴﺔ ﻣﻦ اﻟﻤ
 5629.0 اﻟﻮاﺣﺪ وﻤﻠﻴﻠﺘﺮ ﻣﺎﻳﻜﺮوﺟﺮاﻣﺎت ﻓﻲ اﻟ469.0 اﻟﻄﺮﻳﻘﻪ هﻲ
دّﻗﺔ اﻟﻄﺮﻳﻘِﺔ ﺗﻢ اﻟﺘﺄآﺪ ﻣﻦ  ِ. اﻟﻮاﺣﺪ ﻋﻠﻰ اﻟﺘﻮاﻟﻰﻤﻠﻴﻠﺘﺮﻣﺎﻳﻜﺮوﺟﺮاﻣﺎت ﻓﻲ اﻟ
  اﻟَﻨﺘﺎِﺋَﺞ ﺑﺄّناﻟﺴﻴﻔﺒﺮوزﻳﻞ ﺣﻴﺚ أﻇﻬﺮت  اﻟﺘﺮاآﻴﺰ ﻣﺨﺘﻠﻔِﺔﻋﻴﻨﺎت ﺑﺘﺤﻠﻴﻞ ﺛﻼﺛﺔ
 x60.1 و  3-01 x18.7 ﺑﻴْﻦَﺘﻔﺎوَت ﻳ  وﺾﻣﻨﺨﻔ(  مإ)ﻤﻌﻴﺎرياﻟﻧﺤﺮاف اﻹ
 5-01 x2.3 و  4-01 x77.5، و( اﻟﺘﺤﻠﻴﻞ اﻟﻠﻮﻧﻲ اﻷوﻟﻰﻃﺮﻳﻘﺔ) 2 -01
  . ﻣﻮﻻري5-01 x 9.4و 5-01 x54.2 ﺑﻴﻦﻓﻲ اﻟﻤﺪى  ﻟﻠﺘﺮآﻴﺰ
 اﻻوﻟﻲ ﺑﻨﺠﺎح ﻟﺘﺤﺪﻳﺪ آﻤﻴﺔ  اﻟﻤﺴﺘﺤﺪﺛﺔاﺳﺘﺨﺪﻣﺖ اﻟﻄﺮﻳﻘﺔ
ﻟﻤﺤﺘﻮي اﻟﺴﻴﻔﺒﺮوزﻳﻞ ﻓﻲ ﻋﻴﻨﺎت ﺗﺠﺎرﻳﺔ ﻣﻦ اﻻﻗﺮاص و آﺎﻧﺖ ﻧﺘﻴﺠﺔ ا
ﻟﻠﻄﺮﻳﻘﺔ اﻟﻤﺴﺘﺤﺪﺛﺔ اﻟﺜﺎﻧﻴﺔ آﺎﻧﺖ ﻧﺘﻴﺠﺔ    و ﺑﺎﻟﻨﺴﺒﺔ%78.0±98.99 اﻟﻜﻤﻲ
  ﻟﻸﻗﺮاِص اﻟﺘﺠﺎرﻳِﺔ َآﺎناﻟﻤﺤﺘﻮي اﻟﻜﻤﻲ   %05.0±09.89 اﻟﻤﺤﺘﻮي اﻟﻜﻤﻲ
  . 371.2± %7.001
  اﻟﺘﺤﻠﻴﻞ اﻟﻠﻮﻧﻲﻄﺮﻳﻘﺔﺑﺗﻤﺖ دراﺳﻪ ﻓﺮق اﻻﻣﺘﺼﺎص ﻟﻌﻘﺎر اﻟﺴﻴﻔﺒﺮوزﻳﻞ 
 ﻓﻲ % 71.0±9.4ﺑﻨﺴﺒﺔ  و آﺎﻧﺖ اﻟﻨﺘﻴﺠﺔ وﺟﻮد ﻣﻮاد ﻣﻜﺴﺮة اﻷوﻟﻰ
ﻓﻲ ﺣﺒﻮب  % 82.0±5.5 اﻟﻨﻘﻲ و ﻣﻮاد ﻣﻜﺴﺮة ﺑﻨﺴﺒﺔاﻟﺴﻴﻔﺒﺮوزﻳﻞ
    .اﻟﺴﻴﻔﺒﺮوزﻳﻞ
وﺟﺪ ان ﻣﻌﺪل ﺗﻜﺴﺮ اﻟﺴﻴﻔﺒﺮوزﻳﻞ ﻳﺰداد ﺑﺰﻳﺎدة ﺗﺮآﻴﺰ هﻴﺪروآﺴﻴﺪ 
ﻣﻌﺪل ﻧﺼﻒ اﻟﻌﻤﺮ ﺑﻴﻨﻤﺎ ﺗﻘﻞ ﻗﻴﻤﺔ آﻞ ﻣﻦ (  ﻧﻮرﻣﻞ1و5.0،2.0)اﻟﺼﻮدﻳﻮم
  .و اﻟﻌﻤﺮ اﻹﻓﺘﺮاﺿﻲ
 
  :اﻟﺨﻼﺻﺔ
ﻮي اﻟﻜﻤﻲ ﻟﻠﻄﺮﻳﻘﺔ اﻟﻤﺴﺘﺤﺪﺛﺔ اﻻوﻟﻲ آﺎﻧﺖ ﻧﺘﻴﺠﺔ اﻟﻤﺤﺘ
ﻓﻴﻤﺎ آﺎﻧﺖ ﻧﺘﻴﺠﺔ اﻟﻤﺤﺘﻮي اﻟﻜﻤﻲ ﻟﻠﻄﺮﻳﻘﺔ اﻟﻤﺴﺘﺤﺪﺛﺔ % 78.0±98.99
  .%5.0±09.89اﻟﺜﺎﻧﻴﺔ 
 ﻣﻘﺎرﻧﺔ وﺗﻌﻄﻲ ﻧﻔﺲ اﻟﻨﺘﻴﺠﺔ  َآﺎﻧْﺖ دﻗﻴﻘﺔﺘﺤﺼﻞ ﻋﻠﻴﻬﺎاﻟَﻨﺘﺎِﺋﺞ اﻟﻤ 
 آﻤﺎ أن اﻟﻄﺮﻳﻘﺔ اﻧﺘﻘﺎﺋﻴﻪ ﻟﻠﻌﻘﺎر وﻳﻤﻜﻦ أﺳﺘﺨﺪاﻣﻬﺎ . اﻟﻤﺘﺒﻌﺔﺎﻟﻄﺮﻳﻘِﺔ اﻟﺮﺳﻤﻴِﺔﺑ
  .ﺟﻮد ﻋﻨﺎﺻﺮ أﺧﺮى دون اﻟﺤﻮﺟﺔ اﻟﻰ ﻓﺼﻠﻬﺎﻓﻰ و
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                                              1. INTRODUCTION  
 
 
   1.1.Organism classification:-   
          
           Many of the organisms are classified as either Gram-positive 
or Gram-negative. This classification is based on whether the
organisms do or do not stain with Gram's stain, but it has a
significance far beyond that of an empirical staining reaction. Gram-
positive and Gram-negative organisms are different in several
aespects, at least in the structure of the cell wall, which has
implications for the action of antibiotics.  
The cell wall of Gram-positive organisms is a relatively simple 
structure, 15-50 nm thick. It consists of about 50% peptidoglycan, 
about 40-45% acidic polymer (which results in the cell surface being 
highly polar and carrying a negative charge) and about 5-10% 
proteins and polysaccharides. The strongly polar polymer layer 
influences the penetration of ionised molecules and favours the 
penetration of positively charged compounds, such as streptomycin, 
into the cell. 
 The cell wall of Gram-negative organisms is much more complex. 
From the plasma membrane outwards it consists of the following:  
• a periplasmic space containing enzymes and other components 
• a peptidoglycan layer 2 nm in thickness and forming 5% of the 
cell wall mass; this is often linked to lipoprotein molecules 
which project outwards  
• an outer membrane consisting of a lipid bilayer similar in 
some respects to the plasma membrane; it contains protein 
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molecules and on its inner aspect has lipoprotein that is linked 
to the peptidoglycan  
• complex polysaccharides forming important components of 
the outer surface; these are different in different strains of 
bacteria and are the main determinants of the antigenicity of 
the organism. The complex polysaccharides constitute the 
endotoxins, which, in vivo, trigger various aspects of the 
inflammatory reaction, activating complement, causing fever, 
etc. In addition, there are proteins in the outer membrane that 
form transmembrane water-filled channels, termed 'porins', 
through which hydrophilic antibiotics can move freely. 
Difficulty in penetrating this complex outer layer is probably the 
reason why some antibiotics are less active against Gram-negative 
than Gram-positive bacteria. This is the basis of the extraordinary 
insusceptibility to most antibiotics of Pseudomonas aeruginosa, a 
pathogen which can cause life-threatening infections in neutropenic 
patients and patients with burns and wounds. (Bertram G. Katzug.) 
 
1.2. History of  β-Lactam antibiotics:- 
 
     In 1928, Alexander Fleming, working at St Mary's Hospital in 
London, observed that a culture plate on which staphylococci were 
being grown had become contaminated with a mould of the genus 
Penicillium, and that bacterial growth in the vicinity of the mould 
had been inhibited. He isolated the mould in pure culture and 
demonstrated that it produced an antibacterial substance, which he 
called penicillin. This substance was subsequently extracted and its 
antibacterial effects analyzed by Florey and Chain and their 
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colleagues at Oxford in 1940. They showed that it had powerful 
chemotherapeutic properties in infected mice and that it was non-
toxic. Its remarkable antibacterial effects in humans were clearly 
demonstrated in 1941.(Bertram G. Katzug.) 
 
 
1.3. Cephalosporins:-  
1.3.1. Chemistry:- 
The nucleus of the cephalosporins, 7-aminocephalosporanic acid 
(Figure 1-1), bears a close resemblance to 6-aminopenicillanic acid. 
The intrinsic antimicrobial activity of natural cephalosporins is low, 
but the attachment of various R1 and R2 groups has yielded drugs of 
good therapeutic activity and low toxicity (Figure 1–1). The 
cephalosporins have molecular weights of 400–450. They are soluble 
in water and relatively stable to pH and temperature changes. 
Cephalosporins can be classified into four major groups or 
generations, depending mainly on the spectrum of antimicrobial 
activity. As a general rule, first-generation compounds have better 
activity against gram-positive organisms and the later compounds 
exhibit improved activity against gram-negative aerobic organisms. 
(Bertram G. Katzug.) 
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Figure 1-1 Nucles of cephalosporines structure,and classification 
of cephalosporines  
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1.3.2. Mechanism of action of cephalosporins:- 
      
       Cephalosporins, like all β-lactam antibiotics, inhibit bacterial 
growth by interfering with a specific step in bacterial cell wall 
synthesis. The cell wall is a rigid outer layer that is not found in 
animal cells. It completely surrounds the cytoplasmic membrane 
(Figure 1-2), maintaining the shape of the cell and preventing cell 
lysis from high osmotic pressure. The cell wall is composed of a 
complex cross linked polymer, peptidoglycan (murein,mucopeptide), 
consisting of polysaccharides and polypeptides. The polysaccharide 
contains alternating amino sugars, N-acetylglucosamine and N-
acetylmuramic acid. A five-amino-acid peptide is linked to the N-
acetylmuramic acid sugar. This peptide terminates in D-alanyl-D-
alanine. Penicillin-binding proteins (PBPs) catalyze the trans- 
peptidase reaction that removes the terminal alanine to form a 
crosslink with a nearby peptide, which gives cell wall its structural 
rigidity.  β-lactam antibiotics are structural analogs of the natural D-
Ala-D-Ala substrate and they are covalently bound by PBPs at the 
active site. After a β –lactam antibiotic becomes attached to the PBP, 
the trans peptidation reaction is inhibited (Figure 1-3), peptidoglycan 
synthesis is blocked, and the cell dies. The exact mechanism 
responsible for cell death is not completely understood, but 
autolysins, bacterial enzymes that remodel and break down cell wall, 
are involved. Penicillins and cephalosporins are bactericidal only if 
cells are actively growing and synthesizing cell wall. (Bertram G. 
Katzug.) 
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FIGIURE 1-2 Bacterial cell wall structure & mechanism of 
action of β-lactamase enzyme and β-lactam  antibiotics 
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Figure 1-3 Transpeptidation of bacterial cell wall peptidoglycan                             
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1.4.Cefprozil:- 
1.4.1. Drug Description:- 
     Cefprozil is a semi-synthetic broad-spectrum, second generation  
cephalosporin antibiotic. Cefprozil is a cis and trans isomeric mixture 
( ≥ 90% cis). The chemical name for the monohydrate is (6R,7R)-7-
[(R)-2-Amino-2-(p-hydroxyphenyl)acetamido]-8-oxo-3-propenyl-5-
thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monohydrate, 
and the structural formula is: 
                               
                                           cefprozil chemical structure                                
1.4.2. Physical properties :- 
    Cefprozil is a white to yellowish powder with a molecular formula 
for the monohydrate of C18H19N3O5S•H2O and a molecular weight of 
407.45. 
 1.4.3. Available dosage forms:- 
    Cefprozil is available as:    
           - Tablets 250mg & 500mg 
           - Oral suspension 125mg/5ml and 250mg/5ml.  
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1.4.4. Pharmacology of cefprozil:-                                                                                
1.4.4.5.Pharmacokinetics and metabolism:- 
   The pharmacokinetic data were derived from the capsule 
formulation; however, bioequivalence has been demonstrated for the 
oral solution, capsule, tablet, and suspension formulations under 
fasting conditions. Following oral administration of cefprozil to 
fasting subjects, approximately 95% of the dose was absorbed. The 
average plasma half-life in normal subjects was 1.3 hours, while the 
steady-state volume of distribution was estimated to be 0.23 L/kg. 
The total body clearance and renal clearance rates were 
approximately 3 mL/min/kg and 2.3 mL/min/kg, respectively. 
Average peak plasma concentrations after administration of 250 mg, 
500 mg, or 1 g doses of cefprozil to fasting subjects were 
approximately 6.1, 10.5, and 18.3 µg/mL, respectively, and were 
obtained within 1.5 hours after dosing.  
The bioavailability of the capsule formulation of cefprozil was not 
affected when administered 5 minutes following an antacid.                  
Plasma protein binding is approximately 36% and is independent of 
concentration in the range of 2 µg/mL to 20 µg/mL. In patients with 
reduced renal function, the plasma half-life may be prolonged up to 
5.2 hours depending on the degree of the renal dysfunction. In 
patients with complete absence of renal function, the plasma half-life 
of cefprozil has been shown to be as long as 5.9 hours 
1.4.4.6.Clinical uses:- 
    Cefprozil is indicated for the treatment of patients with mild to 
moderate infections caused by susceptible strains of the designated 
microorganisms in the conditions listed below:                                 
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Upper Respiratory Tract infections: -                                                     
-Pharyngitis/tonsillitis caused by Streptococcus pyogenes.                      
-Otitis Media caused by Streptococcus pneumoniae, Haemophilus 
influenzae (including β-lactamase-producing strains), and Moraxella 
(Branhamella) catarrhalis (including β-lactamase-producing strains). 
-Acute Sinusitis caused by Streptococcus pneumoniae, Haemophilus 
influenzae (including β-lactamase-producing strains), and Moraxella 
(Branhamella) catarrhalis (including β-lactamase-producing strains).          
Lower Respiratory Tract infections: -                                                                         
Secondary Bacterial Infection of Acute Bronchitis and Acute 
Bacterial Exacerbation of Chronic Bronchitis caused by 
Streptococcus pneumoniae, Haemophilus influenzae (including β-
lactamase-producing strains), and Moraxella (Branhamella) 
catarrhalis (including β-lactamase-producing strains).                                                   
Skin And Skin Structure infections: -                                                                          
Uncomplicated Skin and Skin-Structure Infections caused by 
Staphylococcus aureus (including penicillinase-producing 
strains) and Streptococcus pyogenes. Abscesses usually require 
surgical drainage.     To reduce the development of drug-resistant 
bacteria and maintain the effectiveness of cefprozil and other 
antibacterial drugs, cefprozil should be used only to treat or prevent 
infections that are proven or strongly suspected to be caused by 
susceptible bacteria. When culture and susceptibility information are 
available, they should be considered in selecting or modifying 
antibacterial therapy. In the absence of such data, local epidemiology 
and susceptibility patterns may contribute to the empiric selection of 
therapy. (www.rxlist.com/cgi/generic/cefprozi.htm) 
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1.4.4.7.Adverse effects:-  
   The adverse reactions to cefprozil are similar to those observed 
with other orally administered cephalosporins. Cefprozil was usually 
well tolerated in controlled clinical trials. Approximately 2% of 
patients discontinued cefprozil therapy due to adverse events.                                        
The most common adverse effects observed in patients treated with 
cefprozil are:                                                                                  
Gastrointestinal: Diarrhea (2.9%), nausea (3.5%), vomiting (1%), 
and abdominal pain (1%).                                                                          
Hypersensitivity: Rash (0.9%), urticaria (0.1%). Such reactions 
have been reported more frequently in children than in adults.                         
CNS: Dizziness (1%), hyperactivity, headache, nervousness, 
insomnia, confusion, and somnolence have been reported rarely ( < 
1%). All were reversible.                                                                                                 
( www.rxlist.com/cgi/generic/cefprozi.htm) 
1.4.4.8.Drug interactions:- 
   Nephrotoxicity has been reported following concomitant 
administration of aminoglycoside antibiotics and cephalosporin 
antibiotics. Concomitant administration of probenecid doubled the 
AUC for cefprozil. (www.rxlist.com/cgi/generic/cefprozi.htm) 
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1.5. Spectrophotometry: 
The technique of ultraviolet-visible spectrophotometry is one of the 
most commonly used techniques in pharmaceutical and biomedical 
analysis. It has been employed in quantitative purposes and with 
certain limitations for characterization of drugs impurities, 
metabolites and related substances. 
The technique involves the measurement of the amount of ultraviolet 
(190-380nm) or visible (380-800nm) radiation absorbed by a 
substance in solution. 
Absorption of light in both the UV and visible region of the 
electromagnetic spectrum occurs when the energy of the light 
matches the energy required to induce an electronic transition and it 
is associated with vibrational and rotational transsions in the 
molecule. 
Spectral selectivity is induced and/or enhanced by a number of 
chemicals or by instrumental technique such as difference, higher-
derivative and dual wavelength spectrophotometry. 
Spectral interference can often arise from what is known as 
"irrelevant" nonspecific absorption, and from absorption by other 
materials and impurities, which may be present. 
When interference is due to spectral overlap of two or more well- 
defined components, a number of methods are adopted to measure 
the individual concentrations. These methods include the Vierodt 
multi-wavelength technique, least squares deconvolution and second 
or higher derivative spectrophotometry (Anthony et al,). 
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1.6. Quantitative spectrophotometric assay of medicinal 
substances: 
The assay of absorbing substance can be carried out by making a 
solution of the substance in a transparent solvent and measuring its 
absorbance at a suitable wavelength. The wavelength normally 
selected is a wavelength of maximum absorption (λmax) where small 
errors in the settings of the wavelength scale will have little effects 
on the measured absorbance. Ideally, the concentration should be 
adjusted to give an absorbance reading of approximately between 0.4 
- 0.9, around which the accuracy and precision of measurement are 
optimal. It is often preferred to read the absorbance from the 
instrument display under non-scanning conditions, i.e. with the 
monochromator set at the analytical wavelength.  Alternatively, the 
absorbance can be obtained by using a recording double beam 
spectrophotometer (Anthony et al). 
The concentration of the absorbing substance can be calculated from 
the measured absorbance using one of three principal procedures. 
A.  Use of standard absorptivity value procedure: 
 British pharmacopoeia contains absorptivity values for stable 
substances. 
B.  Use of calibration graphs: 
In this procedure, the absorbances of a number of standard solutions 
(4-6) of reference substance at concentrations encompassing the 
sample concentration are measured and a calibration curve of 
absorbance versus concentrations is constructed. Concentration of 
analyte can be read from the resultant graph. 
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C.  Single or double point standardization: 
The single point procedure involves the measurement of absorbance 
of a sample solution and solution of the reference substance; the 
standard and sample solutions are prepared in a similar manner.  
Final concentration of the sample solution should be close to that of 
the standard solution. 
The concentration of the substance in the sample can be calculated 
from the proportional relationship that exists between absorbance 
and concentration, Beer’s law being obeyed for such range of 
concentrations. 
C test = A test x C std / A std 
C test is the concentration of test substance. 
A test is the absorbance of test substance. 
C std is the concentration of standard. 
A std is the absorbance of standard. 
Pharmacopoeial applications include assays for single and mixtures 
of drugs analysis involving colour reactions (Colorimetric methods), 
test for tablet dissolution, limit test for impurities, and assays of bulk 
drugs. Further applications are for physiochemical measurements, 
such as pka or velocity constants in enzymatic reactions. The scope 
of such applications has been significantly extended by methods, 
which can confer additional specificity namely difference 
spectrometry, derivative spectrometry; simultaneous equation 
method, absorbance ratio method, geometric correlation method and 
orthogonal method (Anthony et al). 
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1.7. Difference Spectrometry: 
It is used to improve the selectivity and accuracy of 
spectrophotometric analysis of samples containing absorbing 
interferents. The essential feature of a difference spectrophotometric 
assay is that the measured value is the difference absorbance (∆A) 
between two equimolar solutions of the analyte in different chemical 
forms which exhibit different spectral characteristics. 
The criteria for applying difference spectrophotometry to the assay 
of a substance are that: 
a. Reproducible changes may be induced in the spectrum of the 
analyte by the addition of one or more reagents. 
b. The absorbance of the interfering substances is not altered by the 
reagents. 
The simplest and commonly employed technique for altering the 
spectral properties of the analyte is the adjustment of the pH. pH-
induced difference spectrophotometric assay have been described for 
barbiturates (Beckett et al.). 
 
1.8. Absorbance ratio method: 
It is a modification of the simultaneous equation procedure. It 
depends on the property that, for a substance which obeys Beer's law 
at all wavelengths, the ratio of absorbance at any two wavelengths is 
a constant value independent of concentration or path length. For 
example, two different dilutions of the same substance (figure 1.4) 
give the same absorbance ratio A1/A2. The British pharmacopoeia 
also uses a ratio of absorbances at specified wavelengths in certain 
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confirmatory tests of identity. For example, cyanocobalamin exhibits 
three λ max, at 278 nm, 361nm and 550nm. The A361/A550 is 
required to be 3.30 + 0.15 and the A361/A278 to be 1.79 + 0.09.  
 
Figure1.4: Absorption spectra of two different concentrations of a 
substance. (Reproduced from Beckett et al.) 
In quantitative assay of two components in admixture by the 
absorbance ratio method, absorbances are measured at two 
wavelengths (figure 1.5) one being the λ max of one of the 
component (λ2) and the other being  a wavelength of equal 
absorptivity of the two components (λ1). Two equations are 
constructed and treated simultaneously to get the absolute 
concentrations. This method has been used for the assay of 
trimethoprim and sulphamethoxazole in co-trimoxazole tablets 
(Beckett et al.). 
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Figure1.5: Wavelengths for the assay of substances X and Y in 
admixture by the method of absorbance ratios. 
(Reproduced from Beckett et al.) 
1.9. Orthogonal polynomial method: 
The technique of orthogonal polynomials is another mathematical 
correction procedure which involves more complex calculations than 
the three- point correction procedure. The basis of the method is that 
an absorption spectrum may be represented in terms of orthogonal 
functions as follows: 
A (λ) = PoPo (λ) + p1P2 (λ)   pnPn (λ) 
Where A denotes the absorbance at wavelength λ belonging to a set 
of n+1 equally spaced wavelengths at which the orthogonal 
polynomials, po (λ), P1(λ), P2(λ). . .   Pn (λ) are each defined. This 
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method was applied in the selective assay of phenobarbitone 
combined with phenytoin in a capsule formulation (Beckett et al.).  
1.10. Colorimetric Measurements: 
In colorimetric methods, a drug can be selectively transformed so 
that the spectrum of the product is shifted to the visible region. This 
will minimize interference caused by another drug, formulation 
components or biological substances, thereby conferring a further 
degree of specificity. Moreover, a drug with little or no useful 
absorption can be changed to more highly- absorbing chromophore; 
for example captopril was coupled with DCQ and gave a coloured 
reaction product(figure 1.7) with a λmax at 438 nm (Salah M . 
pharm) 
N
O
OH
O
SH
O
N
Cl
ClCl
+
N
O
OH O
S
N O
Cl
Cl
CaptoprilDCQ
+ HCl
 
Figure 1.6: Proposed Reaction Pathway between DCQ and captopril 
(Salah M . pharm) 
There are several parameters, which require careful and critical 
consideration in colorimetry. Firstly, the colour reagent should be 
selective for the drug molecule itself discriminating against 
degradation products, impurities, and formulation excipients which 
might be present. Secondly, there should be a control of parameters, 
which are likely to affect the colour reaction such as, solvent, pH, 
temperature, reagent excess, order of mixing reagents, and other 
related factors. 
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Moreover, the time required to establish the chromophore should be 
carefully monitored and assessed. Finally, the analytical performance 
should be assessed in terms of recovery, precision, sensitivity and 
linear range (Anthony et al.). 
1.11. Effect of solvents on absorption wavelengths: 
1. Red shift: 
A molecule will dissolve in a solvent if solution leads to a lower 
energy system, that is, if energy changes favour solution. This can be 
expressed on an energy diagram as in figure 1.7. 
 
Figure1.7: The energy difference between π and π* levels is 
decreased in the polar solvents; the absorption wavelength increases 
(red shift) (Reproduced from Robinson) 
Electrons in a π* bonding orbital are more polar than electrons in a π 
bonding orbital. Therefore, if a molecule is dissolved in a polar 
solvent the energy difference will be less than the energy difference 
when the molecule is in a non-polar solvent. 
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As consequence, the absorption maximum is changed to a longer 
wavelength in a polar solvent (Red shift) (Robinson, et al). 
2. Blue shift: 
The n electrons are known to be susceptible to hydrogen bonding 
more than electrons in a π orbital. The energy levels of n electrons 
decrease more than the energy level of electrons in the π* orbital if 
hydrogen's are available in the solvent. 
An energy diagram of such a system is shown in figure1.8.The 
energy involved in the transition n →π* when the solvent is non-
polar is less than the energy involved in the same transition when the 
molecule is in a hydrogen donating solvent. As a consequence, the 
absorption maximum in hydrogen donating solvent will move to a 
shorter wavelength (blue shift) (Robinson, et al). 
 
Figure1.8: Energy differences between n and π* levels increase in 
solvents that can provide H to the lone pair. The absorption 
wavelength decreases (blue shift) 
(Reproduced from Robinson, et al) 
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1.12. Molar ratio method:  
In this method, the concentration of one component is kept fixed and 
that of the other varied to give a series [L] / [M] ratios. The 
absorbance of these solutions, measured at absorption maximum for 
the complex MnLp, increase linearly up to the molar ratio of the 
complex, at which virtually the whole amount of both components is 
complexed (assuming little dissociation). Further addition of 
component L cannot increase the absorbance, and the line becomes 
horizontal or shows a break if component L absorbs at the same 
wavelength (figure 1.9). In rare cases an excess component L may 
cause a decrease in absorbance owing to the stepwise formation of 
higher-order complexes that have smaller values at this wavelength 
(Christian et al,).  
Molar ratio method was used for determination of the stoichiometry 
of the reaction between piperazine and ρ-benzoquinone (reaction 
ratio of ρ-benzoquinone to piperazine was 1:4). 
 
Figure1.9:  Molar ratio method 
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(Reproduced from Christian, et al,) 
a.  Component L. does not absorb at the wavelength of maximum 
absorption for the complex.  
b.  Component L absorbs slightly at the wavelength of maximum 
absorption for the complex.  
c.  An excess of component L causes a decreases in absorbance of 
the complex.  
1.13. Slope ratio method: 
This is similar to the fixed molar ratio method but taking only the 
linear part of the plot when L is fixed and M is varied or M is fixed 
and L is varied.  The ratio of the two slopes gives the reaction ratio 
(Christian et al). 
1.14. Factors affecting formulation stability:- 
Importance of stability:- 
· Extensive chemical degradation leads to a substantial loss of 
potency degradation products may result in adverse effects or be 
unsafe 
· Instability may cause:- 
1- Undesired change in performance, i.e. dissolution and 
bioavailability 
2- Substantial changes in physical appearance of the dosage form 
causing product failures 
Factors affecting drugs stability:- 
1-Drug and excipients: these include 
-Chemical structure. 
-Impurity profile. 
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-Physical form. 
-Moisture content. 
-Particle size. 
-Surface area. 
2- Formulations: these include 
-Drug: excipient ratio. 
-Processing method. 
-mixing and milting. 
-Powder packaging. 
3-Enviromintal conditions 
-Temperature. 
- Humidity. 
-Atmospheric oxidation. 
-Light. 
-Packaging. 
Kinetics of reactions:- 
- zero order reactions 
dc/dt= -K 
-First order reactions 
dc/dt= -Kc so Ln C/C◦= -Kt 
-Second order reactions 
- dc/dt = Kc² 
- Determination of the t½ and T90 :- 
t½ = 0.693/Kobs 
T90 = 0.105/ Kobs 
(Geoff G.Z. Zhangand Wei-Qin) 
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1.15. Examples of methods used for quantitative analysis of 
cefprozil:- 
Some methods used for the assay of cefprozil in bulk, and 
pharmaceutical forms or biological fluids reviewed from the 
literature include 
1 - A high-performance liquid chromatography method was 
developed for the determination of cefprozil diastereomers in human 
plasma. Cefprozil exists as cis and trans isomer at the ratio of 90:10. 
Plasma samples were prepared by protein precipitation using 
acetonitrile, trichloroacetic acid and methylene chloride. After the 
mixtures were vortexed and centrifuged, the aqueous supernatant 
was injected into a reversed-phase C8 column. The mobile phase 
consisted of acetonitrile, glacial acetic acid and distilled water at the 
volume ratio of 5.5:1.75:92.75 (pH 2.7). The signals were monitored 
with UV detection at 280 nm. The calibration curves of cis and trans 
isomer were linear in concentration ranges of 0.1–25 and 0.02–
2.5 µg/mL with the correlation coefficient of 0.9999 and 0.9989, 
respectively. After oral administration of cefprozil in humans, Cmax 
and Tmax of total cefprozil were 18.80 ± 2.14 µg/mL and 2.06 ± 
0.62 h. This method was sensitive with excellent selectivity and 
reproducibility, and was successfully applied to a bioavailability 
study of cefprozil in healthy subjects. (Tae-Hwan Park, et al) 
2- Two simple and selective spectrophotometric methods were 
developed for the quantitative determination of cefoperazone 
sodium, cefadroxil monohydrate, cefprozil anhydrous and 
amoxicillin trihydrate in pure forms as well as in their 
pharmaceutical formulations. The methods are based on the selective 
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oxidation of these drugs with either Ce (IV) or Fe (III) in acid 
medium to give an intense yellow coloured product (λmax=397 nm). 
The reaction conditions were studied and optimized. Beer's plots 
were obeyed in a general concentration range of 5–30 µg ml−1 with 
correlation coefficients not less than 0.9979 for the four drugs with 
the two reagents. The methods were successfully applied to the 
analysis of pharmaceutical formulations containing amoxicillin, 
either alone or in combination with potassium clavulanate, 
flucloxacillin or dicloxacillin. They were also applied to the analysis 
of the other three studied drugs in vials, capsules, tablets and 
suspensions with good recovery; percent ranged from 99.7 (±0.46) to 
100.32 (±1.05) in the Ce (IV) method and 99.6 (±0.50) to 100.3 
(±1.32) in the Fe (III) method. Interferences from other antibiotics 
and additives products were investigated. (Hesham Salem and Gamal 
A. Saleh) 
 
3- Four simple, rapid and accurate methods for spectrophotometric 
determination of cepfrozil are presented. Method I and II depend on 
measuring first derivative peak-trough amplitude of the drug in 0.1 N 
HCl (D[a][1]) and in phosphate buffer pH 7(D[b][1]), respectively. 
Method III and IV are based on measuring the absorbance difference 
(∆A) and first derivative difference (∆D[1]) of buffered cefprozil 
solutions against its acidic solutions as blanks. The proposed 
methods are applied for the determination of the drug in pure and 
dosage forms with good accuracy and precision. These methods have 
been successfully applied for the determination of cumulative 
amounts of cefprozil in urine following an oral dose of 500 mg to a 
human male volunteer. Both the intact drug and its alkaline induced 
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degradation products could be determined in presence of each other 
without interference. The proposed methods proved to be accurate 
and reproducible (Daabees H. G, et al) 
4-A rapid and sensitive chemiluminescence (CL) method using flow-
injection (FI) has been developed for the determination of a second 
generation cephalosporin, cefprozil. The method is based on the CL 
reaction of cefprozil with acidic potassium permanganate and tris 
(2,2′-bipyridyl) ruthenium (II), Ru (bipy)32+. The CL intensity is 
greatly enhanced when quinine sulfate is used as a sensitizer. After 
optimization of the different experimental parameters, a calibration 
graph was obtained over a concentration range of 0.1–3.0 µg ml−1 
with minimum detectability of 0.005 µg ml−1 (S/N = 3).  
The correlation coefficient was 0.9998 (n = 6) with a relative 
standard deviation (%R.S.D.) of 1.63% for 2.0 µg ml−1. The 
proposed method was successfully applied to commercial tablets. 
The average percentage recovery (n = 6) was 99.9 ± 1.40.( Nawal A. 
Alarfaj and Sawsan A. Abd El-Razeq) 
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2. Objectives 
1. Development and optimization of new spectrophotometric 
methods for the quantitative measurement of cefprozil. 
2.     Validation of the developed methods. 
3. Application of the developed methods for quantitative 
measurement of cefprozil in pharmaceutical dosage forms. 
4. Comparison between the developed methods and the official 
methods for quantitative analysis of cefprozil. 
5. Study of the stoichiometry of the reaction between ascorbic 
acid and cefprozil. 
6.      Statistical evaluations of the results. 
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3.1. Materials 
The materials used and their sources are summarized in the 
following table     
Table- (3-1): Materials                                                                                       
Chemical Company Country 
CEFZIL® Tablets 
Cefprozil 500mg / tablet 
Lot No : A9B036 
Registration No :TB/031/19040 
Manufacturing date: 2.2005 
Expiry date: 2.2010 
Squibbe USA 
Cefprozil RS 99.9% (w/w) USP USA 
 
 
 
 
 
 
 
29 
 
3. 2.Reagents: 
The following table summarized the reagent used in the present 
study:- 
Table- (3-2):  
Chemical Company Country 
Dimethyl formamide (DMF) Merck KGA Germany 
Sodium hydroxide 
 
British Drug house  
(B.D.H.) 
England 
Hydrochloric acid British Drug house  
(B.D.H.) 
England 
Ascorbic acid 
 
British Drug house  
(B.D.H.) 
England 
Acetonitrite HPLC grade British Drug house  
(B.D.H.) 
England 
Glacial acetic acid (analytical 
grade) 
British Drug house  
(B.D.H.) 
England 
3. 3.Instruments 
3.3.1.  JASCO V-530 UV/VIS spectrophotometer, Japan 
3.3.2.  Balance KERN ALS 120-4, Germany 
3.3.3.HPLC WATERS 600 with WATERS 2996 
Photodiodarray detector .using Column C18 ,3.9mmx25cm ,5 
microns,at  280nm wavelength ,mobile phase:(acetonitrile:phosphate 
buffer pH 4.4),flow rate 1.0ml/min 
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3.4. Methodology 
The first proposed method 
The following solutions were prepared:- 
Stock Solution of Standard cefprozil:- 
    A mass containing 0.05g of anhydrous cefprozil was accurately 
weighed and transferred into 100 ml volumetric flask, dissolved in 
water, and then the volume was completed to 100 ml with water 
(conc. 500µg/ml)( solution A) 
Stock Solution of Cefprozil Tablets:- 
    20 tabs were accurately weighed and powdered. A mass 
containing an equivalent to 0.05g of anhydrous cefprozil (claimed 
concentration) was accurately weighed and transferred into 100 ml 
volumetric flask, dissolved in water, filtered and completed to 100 
ml with water (claimed conc. 500µg/ml) (solution B). 
Coupling reagent:- 
0.2 g of ascorbic acid was dissolved in 10 ml dimethyl formamide to 
produce 10 ml of 2 %w/v (solution C). 
3.4.1.Methods and Experiments: 
    10 ml of stock (solution A) was transferred into stoppard glass 
tube,3ml of 0.1N NaOH was added; solution was heated for 10 
minutes in boiling  water bath ; solution was allowed to cool for 10 
minutes ;6ml of 0.1N HCL was added to the solution; solution was 
allowed to stand for 10 minutes then transferred into 100 ml 
volumetric flask before volume was completed to 100 ml (solution 
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D) conc. (50 µg/ml) ,The same procedure was carried using solution 
B instead of solution A to produce (solution E) conc. (50 µg/ml). 
 
3.4.2.Construction of calibration curve: 
 Serial dilutions were made from solution D. 1.0ml, 2.0ml, 3.0ml, 
4.0ml and 5.0ml of this solution were transferred into stoppard glass 
tubes, then 4.0ml, 3.0ml,2.0ml,1.0ml and 0.0ml of water were added 
to each tube  respectively. One ml of 2 % w/v freshly prepared 
ascorbic acid was added to each tube then heated for 20 minutes in 
boiling water bath. After cooling, the volumes were then completed 
to 10 ml with water.  
Blank was prepared in the same manner  using 5 ml water instead of 
5 ml of standard cefprozil stock solution. 
UV/VIS spectrophotometer was run in scanning mode from 350 – 
500 nm using above solutions against its blank. The established 
λmax was at 408 nm for this reaction. 
This procedure was repeated 3 times to obtain triplicate standard 
curve readings. 
Table- (3-3): Cefprozil RS Solutions for Construction of 
Calibration Curve 
Solution
oN  
Solution 
D (ml) 
Distilled 
water(ml) 
Solution C 
(ml) 
Distilled 
Water(ml)
Cefprozil RS  
Conc. (ug/ml)
1-1 1.00 4.00 1.00  4.00 5.00 
1-2 1.00 4.00 1.00  4.00 5.00 
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1-3 1.00 4.00 1.00  4.00 5.00 
2-1 2.00 3.00 1.00  4.00 10.00 
2-2 2.00 3.00 1.00  4.00 10.00 
2-3 2.00 3.00 1.00  4.00 10.00 
3-1 3.00 2.00 1.00  4.00 15.00 
3-2 3.00 2.00 1.00  4.00 15.00 
3-3 3.00 2.00 1.00  4.00 15.00  
4-1 4.00 1.00 1.00  4.00 20.00 
4-2 4.00 1.00 1.00  4.00 20.00 
4-3 4.00 1.00 1.00  4.00 20.00 
5-1 5.00 0.00 1.00  4.00 25.00 
5-2 5.00 0.00 1.00   4.00 25.00 
5-3 5.00 0.00  1.00   4.00 25.00 
Blank 0.00 5.00 1.00  4.00 0.00 
 
3.4.3.Construction of cefprozil sample Curve:- 
Serial dilutions were made from solution E. 1.0ml, 2.0ml, 3.0ml, 
4.0ml and 5.0ml of this solution were transferred into Stoppard glass 
tubes, then 4.0ml,3.0ml,2.0ml,1.0ml and 0.0ml of water were added 
to each tube respectively. One ml of 2 % w/v freshly prepared 
ascorbic acid was added to each tube then heated for 20 minutes in 
boiling water bath. After cooling, the volumes were then completed 
to 10 ml with water.  
Blank was prepared in the same manner but  using 5 ml water instead 
of 5 ml of cefprozil sample stock solution.(Table 3-4) 
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UV/VIS spectrophotometer was run in scanning mode from 350 – 
500 nm using above solutions against their blank to compare the UV 
absorption pattern with that of the standard. Readings afterwards 
were recorded at 408 nm. 
 This procedure was repeated 3 times to obtain triplicate sample 
curve readings. 
Table (3- 4): Cefprozil Sample Solutions for Construction of 
calibration Curve 
Solution
oN  
Solution
E (ml) 
Distilled 
water(ml)  
Solution C 
(ml) 
Distilled 
Water(ml)
Cefprozil 
Sample  
Conc. (ug/ml)
1-1 1.00 4.00 1.00  4.00 5.00 
1-2 1.00 4.00 1.00  4.00 5.00 
1-3 1.00 4.00 1.00  4.00 5.00 
2-1 2.00 3.00 1.00  4.00 10.00 
2-2 2.00 3.00 1.00  4.00 10.00 
2-3 2.00 3.00 1.00  4.00 10.00 
3-1 3.00 2.00 1.00  4.00 15.00 
3-2 3.00 2.00 1.00  4.00 15.00 
3-3 3.00 2.00 1.00  4.00 15.00  
4-1 4.00 1.00 1.00  4.00 20.00 
4-2 4.00 1.00 1.00  4.00 20.00 
4-3 4.00 1.00 1.00  4.00 20.00 
5-1 5.00 0.00 1.00  4.00 25.00 
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5-2 5.00 0.00 1.00   4.00 25.00 
5-3 5.00 0.00  1.00   4.00 25.00 
Blank  0.00 5.00 1.00  4.00 0.00 
 
3.4.4.Assay of cefprozil Tablets:- 
Direct standard /sample comparison (proposed method 1) 
Sample:- 
To 3 ml of (solution E), 2 ml of water and 1 ml of 2 % w/v freshly 
prepared ascorbic acid were added, and the volume was completed to 
10 ml with water. 
Standard:- 
To 3 ml of (solution D), 2 ml of water and 1 ml of 2 % w/v freshly 
prepared ascorbic acid were added, and the volume was completed to 
10 ml with water. 
Blank:- 
To 5 ml of water 1 ml of 2 % w/v freshly prepared ascorbic acid was 
added, and the volume was completed to 10 ml with water. 
The absorbances of both the sample and the standard were measured 
at 408 nm against the blank and the content % was calculated. 
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3.4.5. Added recovery (%) Measurement:- 
The following solutions' were prepared:- 
Standard: 
2ml from (solution D) were transferred into stoppard glass tube , 3ml 
of water and 1.0 ml of 2% w/v freshly prepared ascorbic acid were 
added and then heated for 20 minutes in boiling water bath. After 
cooling, the volume was completed to 10 ml with water. The 
absorbance was measured at 408 nm against the blank. 
Tablets 
The same procedure was used, using (solution E) in place of 
standard; the absorbance was measured at 408 nm. 
Mixture: 
To 2 ml of (solution E), 2 ml of (solution D), 1.0ml of water and 1.0 
ml of 2 % w/v freshly prepared ascorbic acid solution were added 
and then heated for 20 minutes in boiling water bath. After cooling, 
the volume was completed to 10 ml with water. The absorbance was 
measured at 408 nm. 
Blank was prepared as under ( 3.4.4) 
3.4.6. Estimation of cefprozil-ascorbic acid complex reaction time 
and stability of the colored complex fomed:- 
Serial dilutions were made from (solution D). 
1.0ml,2.0ml,3.0ml,4.0ml and 5.0ml of this solution were transferred 
into stoppard glass tube, One ml of 2 % w/v freshly prepared 
ascorbic acid was added to each tube, then the volumes were 
completed to 5ml with distilled water by adding 4ml,3ml,2ml,1ml 
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and 0ml of water to each tube respectively. The solutions were 
heated in boiling water bath .The heating time with ascorbic acid was 
varied (5, 10, 15, 20and 30 minutes) to study the effect of time on 
maximum color developments  
For the study of the stability of the color, a solution of the colored 
complex made using 20 µg/ml cefprozil was followed at different 
time intervals 1,2 and 3 hours to check the stability of the formed 
color complex. 
. After cooling, the volumes were then completed to 10 ml with 
water, and the absorbance was measured at 408 nm. 
Blank was prepared in the same manner but  using 5 ml water instead 
of 5 ml of standard cefprozil stock solution. 
3.4.7. Purity of cefprozil in intact bulk and pharmaceutical 
tablets form (Delta A method):- 
A mass of the powdered sample equivalent to 0.05g of cefprozil was 
accurately weighed and transferred into 100 ml volumetric flask, 
dissolved in water, filtered and completed to 100 ml with water 
(conc. 500µg/ml). To 10ml of this solution, 3.0ml of 0.1N NaOH 
was added; solution was heated for 10 minutes in boiling water bath; 
allowed to cool for 10 minutes; 6ml of 0.1N HCL was then added to 
it; and volume completed to 100ml. 
To 3ml of the resultant solution, 1ml of freshly prepared ascorbic 
acid 2%w/v was added, and the volume was completed to 5ml with 
distilled water. The solution was heated for 20 minutes in boiling 
water bath, allowed to cool at room temperature, and the volume was 
completed to 10ml with distilled water (15µg/ml) solution 1. 
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The same procedure was carried for cefprozil RS to obtain solution 
2.  
The method was then repeated for cefprozil in the sample and 
standard solutions without adding 3ml of 0.1N NaOH to obtain 
solution 3 and 4 respectively. 
 The absorbance of the four solutions was measured at 408 nm 
against their blank. 
3.4.8. Molar ratio method for determination of the 
Stoichiometry: 
Fixed ascorbic acid concentration and varied cefprozil 
concentration: 
0.0625 g of standard cefprozil was dissolved in water,3ml of 0.1N 
NaOH were added; solution was heated for 10 minutes in boiling 
water bath ;  allowed to cool for 10 minutes ;6ml of 0.1N HCL was 
then added to it; the resultant solution was completed with water to 
50 ml (concentration 3.067x10-3M). To 0.1 ml, 0.25 ml, 0.5 ml, 0.8 
ml, 1 ml, 1.2 ml and 1.5 ml of cefprozil solution (3.067x10-3M) 4.9 
ml, 4.75 ml, 4.5 ml, 4.2 ml, 4 ml, 3.8 ml, 3.5 ml and 3.2 ml water 
were added respectively, then 1ml of freshly prepared ascorbic acid 
solution (3.067x10-3M) were added to each flask. Solution was 
heated for 20 minutes in a water bath at 100  C, allowed to cool at 
room temperature, and the volume was then completed to 10ml with 
distilled water (Table 3-5). The absorbances of the resulting solutions 
were measured at 408 nm against the blank. The molar ratio of the 
reaction complex was obtained from a plot of molar ratio of cefprozil 
molar ratio over that of ascorbic acid vs. absorbance values  
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Table (3-5): Cefprozil Aliquot Solutions for Molar Ratio Method 
 
Solution 
No 
Sample 
solution(ml) 
Distilled 
water(ml) 
Ascorbic 
acid (ml) 
Distilled 
water(ml) 
Cefprozil 
Final conc 
(M) 
Molar ratio 
cefprozil/as
corbic acid 
1 0.1 4.9 1.0 4.0 3.067 x10-4  0.1 
2 0.25 4.75 1.0 4.0 7.66x10-4 0.25 
3 0.5 4.5 1.0 4.0 15.34 x10-4 0.5 
4 0.8 4.2 1.0 4.0 24.5 x10-4 0.8 
5 1.0 4.0 1.0 4.0 30.67 x10-4 1.0 
6 1.2 3.8 1.0 4.0 36.8 x10-4 1.2 
7 1.5 3.5 1.0 4.0 46 x10-4 1.5 
 
 
The second proposed method 
The following solutions were prepared:- 
Stock Solution of Standard cefprozil:- 
    0.05g of anhydrous cefprozil standard was accurately weighed and 
transferred into 100 ml volumetric flask, dissolved in water, and then 
the volume was completed to 100 ml with water (conc. 500µg/ml). 
Stock Solution of Cefprozil Tablets:- 
    20 tablets were accurately weighed and powdered. A mass of the 
powder equivalent to 0.05g of anhydrous cefprozil was accurately 
weighed and transferred into 100 ml volumetric flask, dissolved in 
water, filtered and completed to 100 ml with water (conc. 500µg/ml). 
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Coupling reagent:- 
4 g of NaOH was dissolved in 100 ml water to produce 100 ml of 1N 
NaOH 
Methods and Experiments: 
   10 ml from stock solutions were diluted to 100 ml with water 
(conc.50 µg/ml), 1ml, 2ml, 3ml, 4ml and 5ml of this solution were 
transferred into stoppard glass tubes, and then 4ml, 3ml, 2ml, 1ml 
and 0ml of water were added to each tube respectively. 1 ml of 1N 
NaOH was added to each tube before heating for 15 minutes in a 
boiling water bath. After cooling, the volumes were then completed 
to 10 ml with water. Blank was prepared in the same manner but  
using 5 ml water instead of 5 ml of standard cefprozil stock solution 
(Table 3-6).                      
The same procedure was repeated for cefprozil in the sample (Table 
3-7).UV/VIS spectrophotometer was run in scanning mode from 350 
– 500 nm using the above solutions against blank. The λmax for this 
reaction was found to be 486 nm.This procedure was repeated 3 
times for both sample and standard to obtain triplicate standard curve 
readings 
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Table- (3-6): Cefprozil RS Solutions for Construction of 
Calibration Curve 
Solution 
No 
Stock 
solution 
µg/ml  
(ml) 
Distilled 
water 
(ml) 
NaOH 
1 N 
(ml) 
Distilled 
water 
(ml) 
Cefprozil 
RS Conc. 
(ug/ml) 
1-1 1 4 1 4 5 
1-2 1 4 1 4 5 
1-3 1 4 1 4 5 
2-1 2 3 1 4 10 
2-2 2 3 1 4 10 
2-3 2 3 1 4 10 
3-1 3 2 1 4 15 
3-2 3 2 1 4 15 
3-3 3 2 1 4 15 
4-1 4 1 1 4 20 
4-2 4 1 1 4 20 
4-3 4 1 1 4 20 
5-1 5 0 1 4 25 
5-2 5 0 1 4 25 
5-3 5 0 1 4 25 
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Table- (3-7): Cefprozil Sample Solutions for Construction of 
Calibration Curve 
Solution 
No 
Stock 
solution 
(ml) 
Distteled 
water 
(ml) 
NaOH 
(ml) 
Distilled 
water 
(ml) 
Cefprozil 
sample 
Conc. 
(ug/ml) 
1-1 1 4 1 4 5 
1-2 1 4 1 4 5 
1-3 1 4 1 4 5 
2-1 2 3 1 4 10 
2-2 2 3 1 4 10 
2-3 2 3 1 4 10 
3-1 3 2 1 4 15 
3-2 3 2 1 4 15 
3-3 3 2 1 4 15 
4-1 4 1 1 4 20 
4-2 4 1 1 4 20 
4-3 4 1 1 4 20 
5-1 5 0 1 4 25 
5-2 5 0 1 4 25 
5-3 5 0 1 4 25 
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4.Results 
 4.1. Results of first proposed method:  
    4.1.1. Construction of Calibration Curve 
The absorbance of solutions (20 ug/ml) was measured at 408 
nm against blank using spectrophotometer as in section (3.4.2). 
 
 Figure- (4-1): UV/VIS Absorption Spectra for the first proposed 
method using conc 20 ug/ml 
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The Absorbance was plotted against the final concentration in 
order to obtain a calibration graph. 
The procedure was carried out three times during the same 
day. The results are shown in Tables (4.1, 4-2 & 4-3) and three 
calibration curves were plotted figures (4-2),(4-3)&(4-4).  
Table- (4-1): Absorption of Cefprozil RS Solutions 1 
Sample # Conc. ug/ml Conc. %(w/v) Conc. M Abs 
1 5 0.0005 1.23 X 10-5 0.098 
2 10 0.001 2.45 X 10-5 0.185 
3 15 0.0015 3.68 X 10-5 0.263 
4 20 0.002 4.9 X 10-5 0.342 
5 25 0.0025 6.14 X 10-5 0.426 
 
 
Figure- (4-2): Cefprozil Calibration Curve using (ug/ml) 
Concentrations (curve1) 
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Table- (4-2): Absorption of Cefprozil RS Solutions 2 
Sample # Conc. ug/ml Conc. %(w/v) Conc. M Abs 
1 5 0.0005 1.23 X 10-5 0.126 
2 10 0.001 2.45 X 10-5 0.198 
3 15 0.0015 3.68 X 10-5 0.29 
4 20 0.002 4.9 X 10-5 0.361 
5 25 0.0025 6.14 X 10-5 0.476 
 
 
 
Figure- (4-3): Cefprozil Calibration Curve using (ug/ml) 
Concentrations (curve 2) 
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Table- (4-3) Absorption of Cefprozil RS Solutions 3 
Sample # Conc. ug/ml Conc. %(w/v) Conc. M Abs 
1 5 0.0005 1.23 X 10-5 0.125 
2 10 0.001 2.45 X 10-5 0.199 
3 15 0.0015 3.68 X 10-5 0.291 
4 20 0.002 4.9 X 10-5 0.36 
5 25 0.0025 6.14 X 10-5 0.467 
 
 
 
Figure- (4-4): Cefprozil Calibration Curve using (ug/ml) 
Concentrations (curve 3) 
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4.1.2. Statistics of calibration curves                                                                  
In order to validate the results, statistic analysis was done for each 
curve and the mean value of each curve readings was calculated 
(Table4-4). The mean value of absorbancses was plotted against final 
concentrations to construct a final calibration curve (Figure 4-5).                                  
Table- (4-4): Statistical Analysis of Calibration curves 
Absorbance 
Sample 
# 
 
Conc. 
ug/ml Conc. 
%w/v 
 
Molar Conc 
mol/L 
Abs 
 
Mean 
 
SD RSD% 
1 0.098 
2 0.126 
3 
5 0.0005 
 
 
1.23X10-5 
 0.125 
0.1163 
 
0.01589 
 
13.6629 
1 0.185 
2 0.198 
3 
10 
0.001 
 
2.45X10-5 
 0.199 
0.194 
 
 
0.00781 4.02577 
1 0.263 
2 0.29 
3 
15 
0.0015 
 
3.68X10-5 
 0.291 
0.2813 
 
 
0.01589 5.64877 
1 0.342 
2 0.361 
3 
20 
0.002 
 
4.9X10-5 
 0.36 
0.3543 
 
 
0.01069 3.0172 
1 0.426 
2 0.476 
3 
25 
0.0025 
 
6.1X 10-5 
 0.467 
0.4563 
 
 
0.02665 5.8405 
47 
 
 
Figure- (4-5): Cefprozil Calibration Curve Using 
Concentrations (ug/ml) (Mean of Absorbance) 
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4.1.2.1. Error of the slope and the intercept and determination of 
detection and quantification limits:- 
Error for the slope (b), intercept (a), and the limit of detection and 
the limit of quantification were all determined statistically (Miller 
and Miller). The results are illustrated in table (4-5).                    
Table (4-5) 
 
Sy/x = √ ∑i (Yi - Ŷi) ² / n-2 = √ 8.748×10-5 /3 = 0.0054 
     
Sb = Sy/x / √ ∑i (Xi – X`) ² = 0.0054 /√ 250 = 3.4153×10-4 
For t value for (n-2) = 3 the 95% confidence level is 5.84, the 95% 
confidence limit for the b is thus 
b=0.0168±5.84×3.4153x10-4 
Slope (b) = 0.0168± 0.001995 
Sa = Sy/x√ ∑i Xi² / n∑i (Xi – X`) ² 
= 0.0054 √ 1375/5 /250 = 0.00566 
So the confidence limit is  
Xi Xi² Yi Ŷi ( Yi -  Ŷi)² ( Xi – 
X`)² 
5 25 0.1163 0.1123 1.6 X10-5 100 
10 100 0.194 0.1964 0.576 X10-5 25 
15 225 0.2813 0.2805 0.064 X10-5 0 
20 400 0.3543 0.3647 0.108 X10-5 25 
25 625 0.4568 0.4488 6.4 X10-5 100 
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a = 0.02835± 5.84× 0.00566 
Intercept (a) = 0.02835 ± 0.033 
Limit of detection 
Y = YB + 3SB 
Y = 0.02835 + 3×0.0054  
Y = 0.04455 
Y= bx + a 
0.04455= 0.0168 x +0.02835 
So the limit of detection is 0.964µg/ml 
 
Limit of Quantification: 
Y = YB + 10 SB 
Y = 0.02835 + 10×0.0054 = 0.08235 
Y = bx + a 
0.08235 = 0.0168 x +0.02835 
X = 3.214 µg/ml 
So the limit of quantification is 3.214µg/ml  
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4.1.3. Construction of Sample Curve 
The absorbance of solutions was measured at 408 nm against 
their blank. The Absorbance was plotted against the final 
concentration in order to obtain a calibration graph. 
The procedure was carried out three times during the same day 
(Tables- (4-6), (4-7) & (4-8)) and 3 calibration curves were plotted 
(Figures (4-6), (4-7) & (4-8))  
Table- (4-6): absorption of Cefprozil sample Solutions 1 
Sample # Conc. ug/ml Conc. %(w/v) 
Conc. 
Mol/L Abs. 
1 5 0.0005 1.23 X 10-5 0.107 
2 10 0.001 2.45 X 10-5 0.195 
3 15 0.0015 3.68 X 10-5 0.288 
4 20 0.002 4.9 X 10-5 0.361 
5 25 0.0025 6.14 X 10-5 0.467 
 
 
Figure- (4-6): Cefprozil sample calibration Curve: 
concentration (ug/ml) vs absorbance (curve 1) 
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 Table- (4-7):   Absorption of Cefprozil sample Solutions 2 
Sample # Conc. ug/ml Conc. %(w/v) Conc. M Abs 
1 5 0.0005 1.23 X 10-5 0.117 
2 10 0.001 2.45 X 10-5 0.196 
3 15 0.0015 3.68 X 10-5 0.292 
4 20 0.002 4.9 X 10-5 0.359 
5 25 0.0025 6.14 X 10-5 0.463 
  
  
Figure- (4-7) Cefprozil sample Curve using (ug/ml) 
Concentrations (curve 2) 
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Table- (4-8): Absorption of Cefprozil sample Solutions 3 
Sample # Conc. ug/ml Conc. %(w/v) Conc. M Abs 
1 5 0.0005 1.23 X 10-5 0.119 
2 10 0.001 2.45 X 10-5 0.199 
3 15 0.0015 3.68 X 10-5 0.292 
4 20 0.002 4.9 X 10-5 0.371 
5 25 0.0025 6.14 X 10-5 0.467 
  
  
Figure- (4-8) Cefprozil sample Curve using (ug/ml) 
Concentrations (curve 3) 
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Figure (4-9) Cefprozil sample Curve Using (ug/ml) 
Concentrations (Mean absorbance)  
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4.1.4. Assay of cefprozil Tablets by the Proposed Method:  
Direct standard/sample comparison was used to assay cefprozil 
tablets by the proposed method (section 3.7.3). The following 
formula was adopted to calculate content of cefprozil, as % w/w of 
the tablet considering equal sample and standard concentrations: 
A Sample / A STD × 100 
A Sample: Absorbance of the sample  
A STD: Absorbance of the standard 
The results are shown in table (4-10) 
4.1.4.1. Assay of Tablets by the Proposed Method using conc. 
15ug/ml:- 
Table- (4-9): Absorbance statistics 
 
Table- (4-10): Content % statistics  
Sample 
ID 
ABS 
 
Content 
(% w/v) 
Mean 
(%w/v)
SD 
(w/v) 
Value range 
 
1 0.292 100.7 
2 0.292 100 
3 0.288 98.97 99.89 0.87 99.89±0.87% 
  
Absorbance
1 
Absorbance  
2 
Absorbance 
3 
Mean 
Absorbance 
SD 
Standard 0.290 0.292 0.291 0.29100 0.001 
Cefzil(sample) 0.292 0.292 0.288 0.29067 0.0023
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Also the following formula was adopted to calculate content of 
cefprozil, as % w/w of the tablet directly from the sample and 
standard curves:-  
(Slope of sample curve/Slope of standard curve) x100 
          -Mean slope of the standard curve=0.017 (table 4-4) 
-Mean slope of the sample curve=0.018 (table4-8) 
Content %=( 0.018/.017)x100=105.88% 
4.1.4.2. Assay of cefprozil tablets using USP method (HPLC) 
Tablets were assayed using official USP method; the results obtained 
are shown in table (4-11). 
 Table- (4-11)  
 
Figures (4-10) and (4-11) shows the chromatograms for cefprozil 
sample compared to similar standard concentration. 
  
 
 
 
 
 
SDMean %Content %standardsample 
98.26073659628Area 1
96.16190659478Area 2
1.81  98.00 
99.75987759697Area3
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Figure- (4-10) HPLC method sample chromatogram  
  
 
 
Figure- (4-11) HPLC method standard chromatogram  
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4.1.4.3. Validation of the proposed method compared to USP 
method using F and t value:- 
Calculated t value = 
(Mean of proposed method) - (Mean of HPLC method) / √ (SD² 
pro/n+SD² hplc/n) 
99.89-98/√0.2523 +1.092 
1.89/1.159=1.63  
So Calculated t value =1.63, and the 95%confidence limit for 4 
degrees of freedom is 2.78(tabulated t value)  
F calculated value = (official method SD)² / (proposed method SD)²  
= (1.81)² / (0.87)² =4.33 
confidences limit =  
Mean ± Calculated t x SD/√n =  
1.63x0.87/√3=1.4181/1.732=0.819  
So 95% confidence limit =99.89±0.819 
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4.1.5. Added recovery (%) by the Proposed Method: 
To determine the added recovery (%) by the proposed method 10 
µg/ml of standard cefprozil solution, 10 µg/ml of cefprozil tablets 
solution and a mixture of both were used (section 3.7.6). The 
recoveries were calculated according to the following formulae: 
A mix-A sample= A standard (1) 
Recovery (%) = (A standard (1) / A standard) x 100 
 
 
Table- (4-12): Added recovery (%) of the Proposed Method  
 
Recovery % = 100.7±2.173 
 
 
 
 
 
 
 
 
SDMeanRecovery (%) A standard A standard (1) A sample A mix 
102.70.1870.1920.1850.3771
98.40.1860.1830.1880.3712
2.173 100.7
101.10.1820.1840.1980.3823
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4.1.6. Estimation of cefprozil-ascorbic acid product reaction time 
and stability of the colored complex form:- 
To optimize the reaction time of the colour produced from the 
reaction of cefprozil with ascorbic acid, a sample of standard 
cefprozil was prepared and the absorbance was recorded at different 
time intervals. The obtained results are shown in table (4-13) and 
figures (4.12), (4-13), (4-14) and (4-15). 
  
Table- (4-13): Estimation of cefprozil-ascorbic acid complex 
reaction time and stability of the colored complex form:  
 
  
  
  
  
 
 
  
  
 
 
  
Absorbance/time(minutes) Conc. 
ug/ml 5  10  15  20  
5 0.103 0.104 0.103 0.107 
10 0.188 0.184 0.186 0.195 
15 0.272 0.265 0.297 0.288 
20 0.367 0.374 0.383 0.361 
25 0.376 0.455 0.476 0.467 
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Figure- (4-12): (Cefprozil –ascorbic acid) product Curve after 5 
minutes  
  
Figure- (4-13): (Cefprozil –ascorbic acid) product Curve after 
10 minutes 
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    Figure- (4-14): (Cefprozil –ascorbic acid) product Curve 
after 15 minutes  
   
Figure- (4-15): (Cefprozil –ascorbic acid) product Curve 
after 20 minutes 
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4.1.7. Stability of the Color using 15 µg\ml of Standard cefprozil:  
To study the stability of the color produced from the reaction of 
cefprozil with ascorbic acid a sample of standard cefprozil was 
prepared and the absorbance was recorded at different time intervals. 
The obtained results are shown in Table (4- 14), figure (4-19) 
Table (4- 14): Absorbance of (crfprozil –ascorbic acid) reaction 
product(Done For 15 µg\ml of Standard    cefprozil)  during 3 
hours:- 
 
Absorbance Time (Hour)  
0.291 0 
0.290 1 
0.292 2 
0.292 3 
 
 
Figure (4-16):-Absorbance of (cefprozil –ascorbic acid) reaction 
product versus time (hours). 
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4.1.8. Purity study of cefprozil in intact bulk and pharmaceutical 
tablets forms (Delta A method), Done For 15 µg\ml of Standard 
and cefprozil tablets):- 
Cefprozil RS 
To determine the degraded amount in cefprozil RS, solution of 15 
µg\ml was prepared as in (3.4.7) with and without adding 3ml (0.1 
N) NaOH and then scanned by spectrophotometer, the results were:- 
Table (4-15): Purity study of cefprozil RS 
So percentage of degraded amount in intact cefprozil RS was 
4.93%±0.167. 
Cefprozil sample 
To determine the degraded amount in cefprozil tablets, solution of 15 
µg\ml was prepared as in (3.4.7) with and without adding 3ml (0.1 
N) NaOH and then scanned by spectrophotometer, the results were:- 
Table (4- 16): Purity study of cefprozil in pharmaceutical tablet 
form  
SDImpurity%MeanRS 3RS 2RS 1 
0.3923 0.391 0.393 0.393 Cefprozil RS 
with NaOH
0.167 4.93 
0.019330.020  0.019 0.019 Cefprozil RS 
without NaOH 
SDImpurity %  MeanSample 3Sample 2Sample 1 
0.274 0.278 0.267 0.276 Cefprozil with 
NaOH
0.28 5.5 
0.015 0.015  0.014 0.016 Cefprozil 
without NaOH 
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So percentage of degraded amount in intact cefzil tablet was 
5.5%±0.28 
4.1.9. Reproducibility& repeatability:-  
In order to evaluate between - days variation (reproducibility) 
and within day variation (repeatability) 3 different conc. of cefprozil 
solutions were assessed in three different days (Table- 4-17) and 
within the same day (Table- 4-18). 
Table (4-17):  Cefprozil sample absorptionin Different days 
Absorbance Conc. 
ug/ml Day1 Day 2 Day 3 Mean SD 
10 0.126 0.124 0.125 0.1250 1 x 10-3 
15 0.198 0.199 0.199 0.1987 1.07 x 10-3 
20 0.290 0.292 0.292 0.2913 1.04 x 10-3 
. 
 
Table (4-18):- Cefprozil Sample Absorption on the same day 
Absorbance Conc. 
ug/ml 1 2 3 Mean SD 
10 0.115 0.112 0.116 0.1143 2.08x 10-3 
15 0.215 0.214 0.213 0.2140 1.00 x 10-3 
20 0.313 0.311 0.309 0.3110 2.00 x 10-3 
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4.1.10. Study of the Stoichiometry of the reaction using molar 
ratio method:  
Fixed Ascorbic acid Concentration against different Cefprozil 
Concentrations. 
3.067x10-3 molar solutions of both cefprozil RS and ascorbic acid 
were prepared as in section (3.4.8) then to 0.1 ml, 0.25 ml, 0.5 ml, 
0.8 ml, 1 ml, 1.2 ml, 1.5 ml and 1.8 ml of cefprozil solution 
(3.067x10-3M) 1ml freshly prepared ascorbic acid was added before 
their volumes were completed to 10ml with distilled water ,then 
scanned using spectrophotometer. 
The results obtained for the study of the stoichomitry of the reaction 
are shown in table (4-19) and figure (figure 4-20).  
Table (4-19): Molar Ratio Method (fixed ascorbic acid conc.) 
 
Conc. of 
cefprozil (M)
No of ml of 
cefprozil Absorbance 
3.067 x10-4 0.1 0.072 
7.66x10-4 0.25 0.144 
15.34 x10-4 0.5 0.285 
24.5 x10-4 0.8 0.43 
30.67 x10-4 1 0.473 
36.8 x10-4 1.2 0.501 
46.02 x10-4 1.5 0.584 
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Figure 4-17: Molar ratio curve ascorbic acid (fixed 
concentration) , cefprozil (varied concentration) 
(Y) axis = absorbance 
(x) axis =numbers of ml of cefprozil 
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4.2.Results of the second proposed method 
4.2.1Assay of cefprozil Tablets by the second Proposed Method: 
Direct standard/sample comparison was used to assay 
cefprozil tablets by the proposed method. The following formula was 
adopted to calculate content of cefprozil, as % w/w of the tablet 
using same concentration of sample and standard: 
A Sample / A STD × 100 
A Sample: Absorbance of the sample  
A STD: Absorbance of the standard 
4.2.2. Construction of Calibration Curve 
The absorbance of solutions (20 ug/ml) was measured at 486 
nm against blank using spectrophotometer as in section 
(3.4.9).
Figure (4-18): UV/VIS Absorption Spectra for the second 
proposed reaction method 
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The Absorbance was plotted against the final concentration in 
order to obtain a calibration graph. 
The procedure was carried out three times during the same day 
(Tables (4-20), (4-21) & (4-22)) and three calibration curves were 
plotted (Figures- (4- 19), (4- 20), (4- 21)) 
 
Table (4-20): Absorption of Cefprozil RS Solutions 1 
Sample # Conc. ug/ml Conc. %(w/v) Conc. M Abs 
1 5 0.0005 1.23 X 10-5 0.114  
2 10  0.001 2.45 X 10-5 0.199 
3 15 0.0015 3.68 X 10-5 0.304 
4 20 0.002 4.9 X 10-5 0.410 
5 25 0.0025 6.14 X 10-5 0.508 
  
 
Figure- (4-19) Cefprozil RS Calibration Curve Using (ug/ml) 
Concentrations (curve 1) 
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Table (4- 21): Absorption of Cefprozil RS Solutions 2 
Sample # Conc. ug/ml Conc. %(w/v) Conc. M Abs 
1 5 0.005 1.23 X 10-5 0.112 
2 10 0.001 2.45 X 10-5 0.199 
3 15  0.0015 3.68 X 10-5 0.303 
4 20 0.002 4.9 X 10-5 0.404 
5 25 0.0025 6.14 X 10-5 0.509 
  
  
  
  
  
Figure- (4-20) Cefprozil RS Calibration Curve Using (ug/ml) 
Concentrations (curve 2) 
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Table (4- 22)-: Absorption of Cefprozil RS Solutions 3 
Sample # Conc. ug/ml Conc. %(w/v) Conc. M Abs 
1 5 0.005 1.23 X 10-5 0.113 
2 10 0.001 2.45 X 10-5 0.198 
3 15  0.0015 3.68 X 10-5 0.303 
4 20 0.002 4.9 X 10-5 0.409 
5 25 0.0025 6.14 X 10-5 0.506 
  
  
  
  
Figure- (4-21) Cefprozil RS Calibration Curve Using (ug/ml) 
Concentrations (curve 3) 
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Table (4-23):  Cefprozil RS mean absorbance's (λ Max 486 nm) 
                                                                   
Conc. 
(µg\ml)
A1 A2 A3 
Mean 
A 
SD 
5 0.114 0.112 0.113 0.1130 10 X 10-4  
10 0.199 0.199 0.198 0.1987 5.77 X 10-4 
15  0.304 0.303 0.303 0.3033 5.77 X 10-4 
20 0.410 0.404 0.409 0.4077 32 X 10-4 
25  0.508 0.509 0.506 0.5077 15 X 10-4 
r = 0.9996     Slope (b) = 0.020    Intercept (a) = 0.003 
  
  
Figure- (4-22) Cefprozil RS Calibration Curve Using (ug/ml) 
Concentrations 
(Mean absorbance)  
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4.2.3. Error of the slope and the intercept and determination of 
detection and quantification limits:- 
Error for The slope (b), intercept (a), and the limit of detection and 
the limit of quantification were all determined statistically (Miller 
and Miller). The results are illustrated in the following table  
Table (4-24)  
 
 
Sy/x = √ ∑i (Yi - Ŷi) ² / n-2 = √ 11.45×10-5 /3 = 0.006178 
       
Sb = Sy/x / √ ∑i (Xi – X`) ² = 0.006178/√ 1000 = 1.954×10-4 
For the t value for (n-2) = 3 ,the 95% confidence level is 5.84 the 95% 
confidence limit for the b is thus 
b=0.02±5.84×1.954×10-4 
Slope (b) = 0.02± 0.00114 
Xi Xi² Yi Ŷi ( Yi -  Ŷi)² ( Xi – X`)² 
5 25 0.1130  0.1064 4.356 X10-5 100 
10 100 0.1987 0.2062 5.625 X10-5 25 
15  225 0.3033 0.3061 0.784 X10-5 0 
20 400 0.4077 0.4059 0.324 X10-5 25 
25 625 0.5077 0.5058 0.361 X10-5 100 
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Sa = Sy/x√ ∑i Xi² / n∑i (Xi – X`) ² 
= 0.006178 √ 5500/5 ×1000 = 0.00648 
So the confidence limit is  
a = 0.003± 5.84× 0.00648 
Intercept (a) = 0.003 ± 0.0378 
Limit of detection:- 
Y = YB + 3SB 
Y = 0.003 + 3×0.006178   
Y = 0.02153 
Y= bx + a 
0.02153= 0.02 x +0.003 
So the limit of detection is 0.9265µg/ml 
Limit of Quantification:- 
Y = YB + 10 SB 
Y = 0.003 + 10×0.006178 = 0.06478 
Y = bx + a 
0.06478= 0.02 x +0.003 
X = 3.089 µg/ml 
So the limit of quantification is 3.089 µg/ml  
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4.2.4. Construction of sample Curves 
The absorbance of solutions was measured at 486 nm against 
its blank. The Absorbance was plotted against the final concentration 
in order to obtain a calibration graph.                                                  
The procedure was carried out three times during the day 
(Tables- (4-25), (4-26) & (4-27)) and 3 calibration curves were 
plotted (Figures- (4-23), (4-24), (4-25)). 
Table (4-25): Absorption of Cefprozil sample Solutions 1 
Sample # Conc. ug/ml Conc. %(w/v) Conc. M Abs 
1 5 0.001 1.23 X 10-5 0.109  
2 10  0.002 2.45 X 10-5 0.19 
3 15  0.003 3.68 X 10-5 0.299 
4 20 0.004 4.9 X 10-5 0.398 
5 25 0.005 6.14 X 10-5 0.478 
 
Figure- (4-23) Cefprozil sample Curve using (ug/ml) 
Concentrations (curve 1) 
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Table (4-26)-: Absorption of Cefprozil sample Solutions2 
Sample # Conc. ug/ml Conc. %(w/v) Conc. M Abs 
1 5 0.001 1.23 X 10-5 0. 112  
2 10  0.002 2.45 X 10-5 0. 21 
3 15  0.003 3.68 X 10-5 0. 301 
4 20 0.004 4.9 X 10-5 0. 411 
5 25 0.005 6.14 X 10-5 0. 501  
  
  
Figure- (4-24) Cefprozil sample Calibration Curve using (ug/ml) 
Concentrations (curve 2) 
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Table (4-27): Absorption of Cefprozil sample Solutions 3 
Sample # Conc. ug/ml Conc. %(w/v) Conc. M Abs 
1 5 0.001 1.23 X 10-5 0. 108  
2 10  0.002 2.45 X 10-5 0. 199 
3 15  0.003 3.68 X 10-5 0. 300 
4 20 0.004 4.9 X 10-5 0. 397 
5 25 0.005 6.14 X 10-5 0. 498  
  
  
  
Figure- (4-25) Cefprozil sample Curve using (ug/ml) 
Concentrations (curve 3) 
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Table (4-28):  Cefprozil sample mean absorbance's (λ Max 486 
nm)  
Conc. 
(µg\ml)
A A A Mean A SD 
5 0.109  0. 112  0. 111  0.1107  0.0015  
10 0.19 0. 21 0. 200 0.2000 0.01  
15  0.299 0. 301 0. 300 0.3000 0.001  
20 0.398 0. 411 0. 405 0.4047 0.0065 
25  0.478 0. 501  0. 489  0.4893 0.0115 
r = 0.999    Slope (b) = 0.019    Intercept (a) = 0.005 
 
Figure- (4-26): Cefprozil sample Curve using (ug/ml) 
Concentrations (Mean absorbance)   
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4.2.5. Assay of cefprozil Tablets by the second Proposed Method: 
Direct standard/sample comparison was used to assay 
cefprozil tablets by the proposed method (section 3.7.3). The 
following formula was adopted to calculate content of cefprozil, as 
% w/w of the tablet using similar sample and standard cncentration: 
A Sample / A STD × 100 
A Sample: Absorbance of the sample  
A STD: Absorbance of the standard 
The results are shown in tables (4- 29), (4- 30) 
Assay of Tablets by the Proposed Method using conc.of 
15ug/ml:- 
Table (4- 29): Absorbance statistics 
  
Table (4- 30): Content % statistics  
Sample 
ID 
ABS 
 
STD M 
(% w/v)
Mean 
(%w/v)
SD 
(w/v) 
Value range 
 
1 0.299 98.36 
2 0.301 99.34 
3 0.300 99.00 98.9 0.498 98.9±0.498 
 
  A1 A2 A3 Mean A SD 
Standard 0.304 0.303 0.303 0.303 0.000577 
Cefzil(sample) 0.299 0.301 0.300 0.300 0.001 
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4.2.6. t calculated value :- 
 (Mean of proposed method) - (Mean of HPLC method) / √ (SD² 
pro/n+SD² hplc/n) 
98.9-98/√0.0827+1.092 
0.9/1.08=0.833 
So Calculated t value =0.833, and the 95%confidence limit for 4 
degrees of freedom is 2.78(t tabulated value)  
F calculated value= (official method SD)² / (proposed method SD)² 
=13.21 
confidences limit =  
Mean ± Calculated t value x SD/√n =  
0.833x0.498 /√3=0.415/1.732=0.24 
So 95% confidence limit =98.9±0.24 
 
4.2.7. Reproducibility  
In order to evaluate between - days variation 3 different conc. 
of cefprozil solutions were assessed in three consecutive days  
Table (4-31): Cefprozil sample absorption in different days  
Absorbance Conc. 
ug/ml Day1 Day 2 Day 3 Mean SD 
10 0.190 0.210 0.200 0.2000  0.01  
15 0.299 0.301 0.300 0.3000 0.001  
20 0.398 0.411 0.405 0.4047 0.0065  
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of cefprozil in alkaline mediaDegredation .8..24  
Using three different normalities of NaOH 0.2, 0.5, &1 N, the effect 
of NaOH concentration on the stability was studied by the official 
USP HPLC method .A plot of log area versus time was done for each 
NaOH concentration figures (4-27), (4-28)& (4-29) 
  
Figure (4-27): Log Area VS Time (minutes) show stability of 
cefprozil in 1N NaOH  
   
  
Figure (4-28): Log Area VS Time (minutes) show stability of 
cefprozil in 0.5N NaOH  
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Figure (4-29): Log Area VS Time (minutes) show stability of 
cefprozil in 0.2N NaOH 
Table (4-32) Values of R² and slopes of the degradation curves of 
different NaOH concentrations:- 
 
 
 
  
  
Concentration 
of NaOH 
1N NaOH 0.5N NaOH 0.2N NaOH 
R² 0.985 0.999 0.997 
Slope -0.033 -0.016 -0.006 
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Figure (4-30): Curve for slope VS concentrations of NaOH(N) 
Kobs= (-slope) x2.303 so: -   
Table (4-33): Values of Kobs of the degradation curves of 
different NaOH concentrations:-  
    
  
Figure (4-31): Curve for Kobs VS concentration of NaOH(N)  
Kobsslope Concentration(N)
0.0138  -0.0060.2
0.0368 -0.0160.5
0.076 0.033- 1
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Table (4-34) Values of t½ and t90 of cefprozil calculated using  
Kobs  value:- 
  
4.2.9. Comparison of accuracy and precision between the 
proposed methods and the HPLC method (official method):- 
Table (4-35):-  
 
t90 
minutes  
t½ 
minutes  
Kobs  Concentration 
mol/L  
7.64 50.22 0.0138  0.2  
2.86 18.83 0.0368 0.5 
1.38 9.12 0.076 1 
 Content% of 
cefprozil ± SD 
t cal 
t(tab) 
F cal 
F(tab) 
The first 
proposed 
method 
99.89±0.87%n=3
 
1.63 
(2.78) 
4.33 
(19) 
The second 
proposed 
method 
98.9±0.498% n=3   0.833 
     (2.78) 
13.21 
(19) 
 
HPLC method 98.0±1.81% n=3   
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4.2.10. Molar absorbtivity and specific absorbance A1%1cm of 
cefprozil, cefprozil – ascorbic acid reaction product (method one) 
and cefprozil-NaOH reaction product (method two):- 
Table (4-36):-  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Method twoMethod oneCefprozil   
7429721210097.5ε (Slope) 
 
181.1176.1247.8A1%1cm 
 
486408280 Max (nm)λ 
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5. Discussion  
Most of the reported methods of analysis of cefprozil are time 
consuming, lacking selectivity, require sophisticated equipment or 
not simple for routine analysis (Tae-Hwan Park et al; Hesham Salem 
and Gamal A. Saleh; Nawal A. Alarfaj and Sawsan A. Abd El-
Razeq) For instance, the most widely used technique for its 
determination is high- performance liquid-chromatography 
Therefore the need for a fast, sensitive, simple and selective method 
is requred, especially for routine quality control analysis of 
pharmaceutical products containing cefprozil.The penicillins or the 
cephalosporines, each as a group, share a common structural feature 
that differs mainly in the side chain attached to the nitrogen of the 6-
aminopenicillanic acid moiety. Some penicillins and cephalosporines 
have amino acid residues incorporated as their N-alkyl side chain, 
e.g. the N-phenylglycyl of ampicillin, cefaclor and cefalexin and the 
N-4-hydroxyphenylglycyl of amoxicillin and cefadroxil. Ascorbic 
acid has been used as a reagent for the colorimetric determination of 
various amino acids.( Pesez and Bartos). 
 Based on the reported reaction of ascorbic acid with amino acids, 
the behavior of the reagent was investigated when allowed to react 
with the penicillins and cephalosporines containing amino acid 
residues in acidic media. Ampicillin, amoxicillin, cefalexin, 
cefadroxil and cefaclor reacted with ascorbic acid in an alkaline 
media and produced a yellow color absorbing maximally at 410 nm 
(ampicillin, amoxicillin, cefadroxil.) and 406 nm (cefalexin and 
cefaclor) (EL-Obeid et al).  
 The essential prerequisites for the quantitation of penicillins and 
cephalosporins by the ascorbic acid method are the presence of a free 
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amino group in the alkyl side chain coupled with the cleavage of the 
β-lactam ring structure in alkaline condition (EL-Obeid et al). 
5.1. Proposed mechanism for reaction of cefprozil and ascorbic 
acid (first proposed method):-       
The reported reaction of cephalosporin having free α- amino group 
with ascorbic acid indicates the possibility of such reaction with 
cefprozil under the condition suggested by EL-Obeid et al scince 
cefprozil have a free α- amino group .The studied reaction revealed 
very similar conditions to that reported by EL-Obeid et al, 1999 with 
a λ max at 408 nm section (4.1.1.)   
  
I  Penilloic acid derivative    II Ascorbic acid 
(Figure5-1) Proposed mechanism for the color – producing 
reaction of cefprozil and ascorbic acid (first proposed method) 
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5.2. Proposed mechanism for reaction of cefprozil and NaOH 
(second proposed method):- 
 It is well documented that the β-lactam rings of penicillins and 
cephalosporins are cleaved under alkaline conditions to form their 
respective penilloic acids (Y.Yamana et al). Some reports suggested 
that β-lactam antibiotics having free α-amino group form under 
alkaline conditions, a cyclic 2,5 –diketopiperazine derivative as 
exemplified for cefadroxil in (Figure5-2). (EL-Obeid et al). 
  
  
 
(Figure5-2) Proposed mechanism for reaction of cefadroxil and 
NaOH 
 
The structure of cefadroxil and cefprozil differ only in the presence 
of the 3- propenyl group instead of 3-methyl group in cefadroxil. The 
chemical name of cefadroxil is (6R,7R)-7-[(R)-2-Amino-2-(p-
hydroxyphenyl)acetamido]-8-oxo-3-methyl-5-thia-1-
azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monohydrate. 
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 COOH
N
S
O
−CH−CONH−HO−
NH2 CH3
 
Chemical structure of cefadroxil  
 
 The chemical name of cefprozil is(6R,7R)-7-[(R)-2-Amino-2-(p-
hydroxyphenyl)acetamido]-8-oxo-3-propenyl-5-thia-1-
azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid monohydrate . 
 
Chemical structure of cefprozil  
 
Therefore a similar scheme for the alkaline hydrolysis of cefprozil, to 
that of cefadroxil is proposed . The possibly formed 2,5 
diketopiperazine is most likely the color species that  gave the 
maximum absorbance at 486 nm reported in this study section 
(4.2.2.). This strengthen the suggestion by El Obied et al who 
pointed out that the formation of the 2,5 diketopiperazine is  possible 
at high NaOH concentration and long heating time. The optimum 
condition for such reaction was obtained using 1N NaOH with 
heating at 100  C for 15 minutes (second proposed method). 
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OH
HO−
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(Figure5-3) Proposed mechanism for the color – producing 
reaction of cefprozil and NaOH (second proposed method) 
During the study of the optimum conditions of the reaction of 
cefprozil with ascorbic acid (section 5.2), The formation of a faint 
color when 0.1 N NaOH was added to the solution of cefprozil was 
noticed. The intensity of the faint color was observed to increase 
with time. It was tempting to study the direct reaction of cefprozil 
with NaOH at different concentrations (0.2, 0.5 and 1 N) section 
(4.2.8). 
5.3. Study of degradation of cefprozil by NaOH :- 
The degradation of cefprozil with NaOH   at different concentrations 
and time was studied using the HPLC method. 
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5.3.1.Degradation of cefprozil using 1 N NaOH :- 
 
(Figure5-4) HPLC chromatogram of cefprozil at 0 times using 1 
N NaOH 
-Retention time of cefprozil = 8.822 minutes 
-Area % at 0 time = 100 % 
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(Figure5-5): HPLC chromatogram of cefprozil after 35 minutes  
using 1 N NaOH 
 
-Retention time of degraded cefprozil = 8.964 minutes 
-Area % after 35 minutes = 5.7 % 
This study verified that the USP HPLC method is stability indicating. 
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5.3.2. Degradation of cefprozil using three different 
concentrations of NaOH :- 
Using the HPLC method log area VS time was plotted for the three 
concentrations of  NaOH  to produce three curves which indicated 
linear increase in the degradation of the cefprozil by increasing the 
concentration of NaOH figures  (4-27), (4-28)&(4-29). The slopes of 
the curves VS NaOH concentrations were plotted figure (4-30). The 
study revealed an increase in color intensity with incresed NaOH 
concentration with subsequent increase in the rate of reaction (Kobs) 
figure (4-31). 
The Kobs value was used to determine the t½ and T90 of the cefprozil; 
increasing NaOH concentration decreased the t½ and T90 of cefprozil 
due to increased degradation rate table (4-34). 
5.4 Reaction Conditions Optimization 
The different experimental parameters affecting the color 
development were extensively studied to determine the optimal 
conditions for the assay procedure. All conditions studied were 
optimized at room temperature (25 ± 1°C). 
 The optimal volume and concentration for the ascorbic acid 
reagent required in the first proposed method was found to be 1.0 ml 
of 2% w/v in dimethyl formamide. The sequence of addition of the 
reagents as described in the method was found to be essential for 
good reproducibility. Under these conditions the color of the 
complex was immediately formed and was stable for at least 3 hours 
(table4-14) figure (4-16). 
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The conditions for the reaction of cefprozil and NaOH (the 
second proposed method) were also optimized, section (5.2). 
5.5. Reproducibility and Repeatability: 
In order to evaluate between - days variation (reproducibility) and 
within day variation (repeatability) three different concentrations of 
cefprozil solutions were assessed in different days and in the same 
day using the same conditions  .The results showed that both 
methods are satisfactorily reproducible and repeatable (minimum SD 
was 1.00 x 10-3) tables (4-17), (4-18) and (4-31).  
5.6. Minimum Detectable Concentration: 
On application of the methods a minimum detectable concentration 
of 0.964µg/ml was obtained for cefprozil in the first proposed 
method (section4.1.2.1.1), and 1.853 µg/ml for the second proposed 
method (section 4.2.3.1). 
5.7. Added recovery %: 
The accuracy of the first proposed method was checked by recovery-
testing. The results showed good recovery (100.7%±2.174, table 4-
12).It can be seen that complete recovery (almost 100%) was 
obtained by the proposed method indicating no interference with the 
tablets excipients &good precision and accuracy of the method. 
5.8. Purity study of cefprozil in intact bulk and pharmaceutical 
tablets forms (Delta A method):- 
Percentage of impurities in cefprozil tablets and standard was studied 
using the first proposed method, and the results were 5.5%±0.28 
(table 4-16), and 4.93%±0.167 (Table 4-15) respectively. Hence the 
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first proposed method can be considered as stability-indicating 
method for the determination of intact cefprozil in the presence of 
decomposition products that can respond to this reaction. 
This test cannot be applied in the second proposed method, so the 
method cannot be considered as stability-indicating method 
5.9. Analytical Curves: 
Beer’s law was obeyed in the concentration range of 5 – 25 µg/ml of 
cefprozil, in the final solution with a correlation coefficient r = 
0.9975; for the first proposed method. The slope (b) is 0.168 ± 
0.001995 (n = 5) and the intercept (a) is 0.02835 ± 0.033.  For the 
second proposed method the slope (b) is 0.01 ± 0.00114 (n = 5) and 
intercept (a) is 0.003 ± 0.0378. The limit of detection and limit of 
quantification were 0.964 µg/ml and 3.214µg/ml cefprozil, 
respectively for the first proposed method and 1.853 µg/ml 
and6.178µg/ml respectively for the second proposed method section 
(4.1.2.1) & (4.2.3). 
 The minimum detectable concentration is defined here as the 
smallest amount of an analyte which can be detected by a particular 
method (David, 1999). 
5.10. Validation of the proposed method compared to USP 
method using F and t value:- 
In the present work two colorimetric methods for determination of 
cefprozil were developed. The applicability of the two proposed 
methods was assessed by analyzing the pharmaceutical formulation 
of cefprozil (cefzil) and statistically the results were compared with 
HPLC method using F test and t-test.  
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For the first proposed method calculated t value was1.7, and the 
95%confidence limit for 4 degrees of freedom is 2.78(t tabulated 
value) So 95% confidence limit is 99.9±0.002 (section 4.1.4.3). For 
the second proposed method t calculated value was0.9, and the 
95%confidence limit for 4 degrees of freedom was 2.78(t tabulated 
value) So 95% confidence limit is 98.9±0.259 (section 4.2.6). t-test is 
used to test the accuracy of the new method compared with a 
reference method, while F-test is used to check the precision of a 
method compared with a reference method (Miller and Miller). 
These results and the results in table (4-35) section 4.2.10.  , 
indicated that the two proposed methods have good precision and 
accuracy compared to the USP method. 
  
5.11. Study of the Stoichiometry of the Reaction using molar 
ratio method: 
The curve obtained (Figure 4-17) shows a break point at cefprozil 
concentration of 24.5x10-4 M, (0.86 ml). 
 The molar ratio of cefprozil: ascorbic acid was found to be 1 : 0.86 
which indicated 1:1 ratio. 
5.12. Factors affecting stability of cefprozil and color formation:- 
5.12.1 Temperature 
The reaction was apparently very slow at room temperature (25  
C).Only the maximum color development was obtained at 100 C 
and this was taken as the optimum temperature for the two methods. 
Also this indicated that the reaction rate increased by increasing 
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temperature; so degradation rate of the drug increased with 
temperature. 
5.12.2. Reaction time:- 
5.12.2. 1.Estimation of cefprozil-ascorbic acid product reaction 
time and stability of the colored complex formed (first proposed 
method):- 
The formation of cefprozil-ascorbic acid product increased with 
increasing time( table 4-13, figures 4-12, 4-13, 4-14 and 4-15); so 
degradation of cefprozil increased with increasing time of reaction 
with ascorbic acid. Thus 15 to 20 minutes heating time was found to 
be satisfactory for reproducible results. 
5.12.2.2. Estimation of cefprozil-NaOH product reaction time 
and its stability (second proposed method):- 
The degradation of cefprozil by NaOH increased linearly with 
increasing time, figures (4-27), (4-28) and (4-29); so degradation of 
cefprozil increased with increasing time of reaction with NaOH. 
5.12.3. Concentration of the reagent:- 
The reaction rate and maximum absorbance increased with increase 
in ascorbic acid concentration. The optimal concentration for the 
ascorbic acid reagent required was found to be 1.0 ml of 2% w/v in 
dimethyl formamide (first proposed method). All these conditions 
were found in good agreement with those reported by EL-Obeid et 
al. 
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In the second proposed method the optimal concentration of NaOH 
that gave the highest intensity of the formed color was 1 N with 
heating at 100 C  
5.13. Comparison between the first and the second proposed 
methods: -  
Table (5-1) 
 First proposed 
method 
second proposed 
method 
1-Procedure steps indirect reaction 
between cefprozil 
and ascorbic acid 
Direct reaction 
between cefprozil 
and NaOH 
2-Time of method Longer procedure 
,take about 1 hour 
Shorter procedure 
,take about 25 
minutes 
3-Reagents 0.1 N NaOH,0.1 N 
HCL,DMF and 
ascorbic acid 
1 N NaOH 
4-Heating steps Two heating steps 
̣̣̣̣-10miutes heating 
with NaOH 
-20 minutes heating 
with ascorbic acid 
One heating step(15 
minutes with NaOH) 
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5-Stability - indicting  
property 
Delta A method 
applicable 
Not applicable 
 
From the above table (5-1), it is clear that the second proposed 
method is more simple, less time consuming, less reagent 
consuming, affordable and from which t½ andt90can be calculated. 
However the first proposed method has the advantage over the 
second one by having stability indicating property using ∆A method 
which is not applicable in the second proposed method. 
5.14. Comparison between the proposed methods and the other 
methods used in the assay of cefprozil (section 1.5):- 
-The HPLC method (official method)  is the most efficient stability 
indicating method .However, and for developing countries  it is 
considered sophisticated, expensive and time consuming. 
The other reported methods are:-  
- Complicated, expensive using many reagents(Tae-Hwan Park et 
al)&( Nawal A. Alarfaj and Sawsan A. Abd El-Razeq).  
- Depend on selective oxidation of cefprozil using Ce and 
Fe(Hesham Salem and Gamal A. Saleh)   
5.15 Advantages of the Developed Methods: 
The spectrophotometric methods developed for cefprozil assay in 
this work were meant to be simple, sensitive and easily applicable in 
routine work. 
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. They outweigh most of the reported methods in:  
• Being simple: only direct reaction between cefprozil and 
ascorbic acid (first proposed method) and direct reaction 
between cefprozil and 1 N NaOH (second proposed method) 
which does not incorporate complicated and long procedures. 
•  Use of simple, non expensive, non sophisticated and available 
instrument  (the spectrophotometer) 
• Use of few reagents. 
• No extraction step.  
• Suitable concentration range. 
• Good stability of the colour (stable for at least 3 hrs).  
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6. Conclusions & Recommendations 
•  From the present study, the developed methods are expected  
to be suitable as a routine analytical procedure for analysis of 
cefprozil in bulk and in tablet form. The obtained results were 
comparable with USP results. 
• This study indicated that tablet excipients in the dosage forms 
used in the study do not interfere with the proposed methods. 
• The methods can be tried for determination of cefprozil in 
biological fluids and in other pharmaceutical dosage forms 
such as oral suspension (which is not available in Sudan). 
• To elucidate the structure of the reaction product, NMR, 
elemental analysis and mass spectrometry studies are 
recommended. 
• The second proposed method is shown to be more simple 
(5.13.) and more accurate (5.12.) than the first proposed 
method. 
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